TY - JOUR A1 - Üçeyler, Nurcan A1 - Schäfer, Kristina A. A1 - Mackenrodt, Daniel A1 - Sommer, Claudia A1 - Müllges, Wolfgang T1 - High-Resolution Ultrasonography of the Superficial Peroneal Motor and Sural Sensory Nerves May Be a Non-invasive Approach to the Diagnosis of Vasculitic Neuropathy JF - Frontiers in Neurology N2 - High-resolution ultrasonography (HRUS) is an emerging new tool in the investigation of peripheral nerves. We set out to assess the utility of HRUS performed at lower extremity nerves in peripheral neuropathies. Nerves of 26 patients with polyneuropathies of different etiologies and 26 controls were investigated using HRUS. Patients underwent clinical, laboratory, electrophysiological assessment, and a diagnostic sural nerve biopsy as part of the routine work-up. HRUS was performed at the sural, tibial, and the common, superficial, and deep peroneal nerves. The superficial peroneal nerve longitudinal diameter (LD) distinguished best between the groups: patients with immune-mediated neuropathies (n = 13, including six with histology-proven vasculitic neuropathy) had larger LD compared to patients with non-immune-mediated neuropathies (p < 0.05) and to controls (p < 0.001). Among all subgroups, patients with vasculitic neuropathy showed the largest superficial peroneal nerve LD (p < 0.001) and had a larger sural nerve cross-sectional area when compared with disease controls (p < 0.001). Enlargement of the superficial peroneal and sural nerves as detected by HRUS may be a useful additional finding in the differential diagnosis of vasculitic and other immune-mediated neuropathies. KW - peripheral neuropathy KW - nerve ultrasonography KW - vasculitis KW - sural nerve KW - superficial peroneal nerve Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-146671 VL - 7 IS - 48 ER - TY - JOUR A1 - Yadav, Preeti A1 - Selvaraj, Bhuvaneish T. A1 - Bender, Florian L. P. A1 - Behringer, Marcus A1 - Moradi, Mehri A1 - Sivadasan, Rajeeve A1 - Dombert, Benjamin A1 - Blum, Robert A1 - Asan, Esther A1 - Sauer, Markus A1 - Julien, Jean-Pierre A1 - Sendtner, Michael T1 - Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling JF - Acta Neuropathologica N2 - In neurons, microtubules form a dense array within axons, and the stability and function of this microtubule network is modulated by neurofilaments. Accumulation of neurofilaments has been observed in several forms of neurodegenerative diseases, but the mechanisms how elevated neurofilament levels destabilize axons are unknown so far. Here, we show that increased neurofilament expression in motor nerves of pmn mutant mice, a model of motoneuron disease, causes disturbed microtubule dynamics. The disease is caused by a point mutation in the tubulin-specific chaperone E (Tbce) gene, leading to an exchange of the most C-terminal amino acid tryptophan to glycine. As a consequence, the TBCE protein becomes instable which then results in destabilization of axonal microtubules and defects in axonal transport, in particular in motoneurons. Depletion of neurofilament increases the number and regrowth of microtubules in pmn mutant motoneurons and restores axon elongation. This effect is mediated by interaction of neurofilament with the stathmin complex. Accumulating neurofilaments associate with stathmin in axons of pmn mutant motoneurons. Depletion of neurofilament by Nefl knockout increases Stat3-stathmin interaction and stabilizes the microtubules in pmn mutant motoneurons. Consequently, counteracting enhanced neurofilament expression improves axonal maintenance and prolongs survival of pmn mutant mice. We propose that this mechanism could also be relevant for other neurodegenerative diseases in which neurofilament accumulation and loss of microtubules are prominent features. KW - Amyotrophic-lateral-sclerosis KW - Transgenic mice KW - Mouse model KW - Alzheimers disease KW - Neurofilament KW - Progressive motor neuronopathy KW - Axonal transport KW - Intermediate filaments KW - Motoneuron disease KW - Lacking neurofilaments KW - Missense mutation KW - Axon degeneration KW - Microtubules KW - Stathmin KW - Stat3 Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-188234 VL - 132 IS - 1 ER - TY - JOUR A1 - Wiessler, Anna-Lena A1 - Talucci, Ivan A1 - Piro, Inken A1 - Seefried, Sabine A1 - Hörlin, Verena A1 - Baykan, Betül B. A1 - Tüzün, Erdem A1 - Schaefer, Natascha A1 - Maric, Hans M. A1 - Sommer, Claudia A1 - Villmann, Carmen T1 - Glycine receptor β–targeting autoantibodies contribute to the pathology of autoimmune diseases JF - Neurology: Neuroimmunology & Neuroinflammation N2 - Background and Objectives Stiff-person syndrome (SPS) and progressive encephalomyelitis with rigidity and myoclonus (PERM) are rare neurologic disorders of the CNS. Until now, exclusive GlyRα subunit–binding autoantibodies with subsequent changes in function and surface numbers were reported. GlyR autoantibodies have also been described in patients with focal epilepsy. Autoimmune reactivity against the GlyRβ subunits has not yet been shown. Autoantibodies against GlyRα1 target the large extracellular N-terminal domain. This domain shares a high degree of sequence homology with GlyRβ making it not unlikely that GlyRβ-specific autoantibody (aAb) exist and contribute to the disease pathology. Methods In this study, we investigated serum samples from 58 patients for aAb specifically detecting GlyRβ. Studies in microarray format, cell-based assays, and primary spinal cord neurons and spinal cord tissue immunohistochemistry were performed to determine specific GlyRβ binding and define aAb binding to distinct protein regions. Preadsorption approaches of aAbs using living cells and the purified extracellular receptor domain were further used. Finally, functional consequences for inhibitory neurotransmission upon GlyRβ aAb binding were resolved by whole-cell patch-clamp recordings. Results Among 58 samples investigated, cell-based assays, tissue analysis, and preadsorption approaches revealed 2 patients with high specificity for GlyRβ aAb. Quantitative protein cluster analysis demonstrated aAb binding to synaptic GlyRβ colocalized with the scaffold protein gephyrin independent of the presence of GlyRα1. At the functional level, binding of GlyRβ aAb from both patients to its target impair glycine efficacy. Discussion Our study establishes GlyRβ as novel target of aAb in patients with SPS/PERM. In contrast to exclusively GlyRα1-positive sera, which alter glycine potency, aAbs against GlyRβ impair receptor efficacy for the neurotransmitter glycine. Imaging and functional analyses showed that GlyRβ aAbs antagonize inhibitory neurotransmission by affecting receptor function rather than localization. KW - autoantibody (aAb) KW - glycine receptor (GlyR) KW - stiff-person syndrome (SPS) KW - clinical neurology KW - movement disorders KW - progressive encephalitis with rigidity and myoclonus (PERM) Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-349958 VL - 11 IS - 2 ER - TY - JOUR A1 - Wieland, Annalena A1 - Strissel, Pamela L. A1 - Schorle, Hannah A1 - Bakirci, Ezgi A1 - Janzen, Dieter A1 - Beckmann, Matthias W. A1 - Eckstein, Markus A1 - Dalton, Paul D. A1 - Strick, Reiner T1 - Brain and breast cancer cells with PTEN loss of function reveal enhanced durotaxis and RHOB dependent amoeboid migration utilizing 3D scaffolds and aligned microfiber tracts JF - Cancers N2 - Background: Glioblastoma multiforme (GBM) and metastatic triple-negative breast cancer (TNBC) with PTEN mutations often lead to brain dissemination with poor patient outcome, thus new therapeutic targets are needed. To understand signaling, controlling the dynamics and mechanics of brain tumor cell migration, we implemented GBM and TNBC cell lines and designed 3D aligned microfibers and scaffolds mimicking brain structures. Methods: 3D microfibers and scaffolds were printed using melt electrowriting. GBM and TNBC cell lines with opposing PTEN genotypes were analyzed with RHO-ROCK-PTEN inhibitors and PTEN rescue using live-cell imaging. RNA-sequencing and qPCR of tumor cells in 3D with microfibers were performed, while scanning electron microscopy and confocal microscopy addressed cell morphology. Results: In contrast to the PTEN wildtype, GBM and TNBC cells with PTEN loss of function yielded enhanced durotaxis, topotaxis, adhesion, amoeboid migration on 3D microfibers and significant high RHOB expression. Functional studies concerning RHOB-ROCK-PTEN signaling confirmed the essential role for the above cellular processes. Conclusions: This study demonstrates a significant role of the PTEN genotype and RHOB expression for durotaxis, adhesion and migration dependent on 3D. GBM and TNBC cells with PTEN loss of function have an affinity for stiff brain structures promoting metastasis. 3D microfibers represent an important tool to model brain metastasizing tumor cells, where RHO-inhibitors could play an essential role for improved therapy. KW - 3D tumor model KW - 3D microfiber KW - amoeboid cell migration KW - brain cancer KW - breast cancer KW - PTEN KW - RHO KW - ROCK KW - durotaxis KW - topotaxis Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-248443 SN - 2072-6694 VL - 13 IS - 20 ER - TY - JOUR A1 - Wetzel, Andrea A1 - Jablonka, Sibylle A1 - Blum, Robert T1 - Cell-autonomous axon growth of young motoneurons is triggered by a voltage-gated sodium channel JF - Channels (Austin) N2 - Spontaneous electrical activity preceding synapse formation contributes to the precise regulation of neuronal development. Examining the origins of spontaneous activity revealed roles for neurotransmitters that depolarize neurons and activate ion channels. Recently, we identified a new molecular mechanism underlying fluctuations in spontaneous neuronal excitability. We found that embryonic motoneurons with a genetic loss of the low-threshold sodium channel Na\(_V\)1.9 show fewer fluctuations in intracellular calcium in axonal compartments and growth cones than wild-type littermates. As a consequence, axon growth of Na\(_V\)1.9-deficient motoneurons in cell culture is drastically reduced while dendritic growth and cell survival are not affected. Interestingly, Na\(_V\)1.9 function is observed under conditions that would hardly allow a ligand- or neurotransmitter-dependent depolarization. Thus, Na\(_V\)1.9 may serve as a cell-autonomous trigger for neuronal excitation. In this addendum, we discuss a model for the interplay between cell-autonomous local neuronal activity and local cytoskeleton dynamics in growth cone function. KW - spontaneous excitation KW - spinal muscular atrophy KW - axon growth KW - sodium channel KW - motoneurons KW - local protein synthesis KW - NaV1.9 Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-132586 VL - 7 IS - 1 ER - TY - THES A1 - von Wardenburg, Niels Oliver T1 - Investigations into the Pathogenic Antibody-Antigen-Interference of Glycine Receptor Autoantibodies T1 - Untersuchungen zur pathogenen Antikörper-Antigen-Interferenz von Autoantikörpern gegen den Glycinrezeptor N2 - Anti-glycine receptor (GlyR) autoantibodies belong to the novel group of autoantibodies that target neuronal cell-surface antigens (NCS), which are accompanied with various neurologic and neuropsychiatric conditions. The inhibitory ionotropic GlyR is one of the major inhibitory neurotransmitter receptors and therefore involved in maintaining homeostasis of neuronal excitation levels at brain stem and spinal cord. Anti-GlyR autoantibodies are associated with progressive encephalomyelitis with rigidity and myoclonus or stiff person syndrome. These neuromotor disorders are characterized by exaggerated startle, muscle stiffness, and painful spasms, leading to immobility and fatal outcome in some cases. It was hypothesized that imbalance of motoneuronal inhibition by functional impairment of GlyR and receptor internalization are direct consequences of antibody-antigen interference. Here, serum samples of four patients were tested for anti-GlyR autoantibodies and were used for the analysis of the functional impact on the electrophysiological properties of recombinant GlyRs, transiently expressed in HEK293 cells. Furthermore, the recognition pattern of anti- GlyR autoantibodies to human, zebrafish and chimeric GlyRα1 located the epitope to the far N-terminal region. The pathogenicity of anti-GlyR autoantibodies and thereby the autoimmunologic etiology of the disease was confirmed by passive transfer of patient serum to zebrafish (Danio rerio) larvae, that yielded an abnormal escape response – a brain stem reflex that corresponds to the exaggerated startle of afflicted patients. The phenotype was accompanied by profound reduction of GlyR clusters in spinal cord cryosections of treated zebrafish larvae. Together, these novel insights into the pathogenicity of GlyR autoantibodies confirm the concept of a novel neurologic autoimmune disease and might contribute to the development of innovative therapeutic strategies. N2 - GlyR Autoantikörper sind mit dem Stiff-Person-Syndrom assoziiert, insbesondere mit der schwerverlaufenden Variante der Progressiven Enzephalopathie mit Rigidität und Myoklonus. Diese Studie hat sich als Ziel gesetzt, die Pathogenität der Autoantikörper sowie deren pathogenen Eigenschaften mit Hilfe der Patch-Clamp-Methode sowie eines passiven Transfers der Erkrankung auf Zebrafischlarven zu erklären. ... KW - stiff person syndrome KW - glycine receptor autoantibodies Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-247217 ER - TY - JOUR A1 - von Collenberg, Cora R. A1 - Schmitt, Dominique A1 - Rülicke, Thomas A1 - Sendtner, Michael A1 - Blum, Robert A1 - Buchner, Erich T1 - An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance JF - Biology Open N2 - Synapse-associated protein 1 (Syap1) is the mammalian homologue of synapse-associated protein of 47 kDa (Sap47) in Drosophila. Genetic deletion of Sap47 leads to deficiencies in short-term plasticity and associative memory processing in flies. In mice, Syap1 is prominently expressed in the nervous system, but its function is still unclear. We have generated Syap1 knockout mice and tested motor behaviour and memory. These mice are viable and fertile but display distinct deficiencies in motor behaviour. Locomotor activity specifically appears to be reduced in early phases when voluntary movement is initiated. On the rotarod, a more demanding motor test involving control by sensory feedback, Syap1-deficient mice dramatically fail to adapt to accelerated speed or to a change in rotation direction. Syap1 is highly expressed in cerebellar Purkinje cells and cerebellar nuclei. Thus, this distinct motor phenotype could be due to a so-far unknown function of Syap1 in cerebellar sensorimotor control. The observed motor defects are highly specific since other tests in the modified SHIRPA exam, as well as cognitive tasks like novel object recognition, Pavlovian fear conditioning, anxiety-like behaviour in open field dark-light transition and elevated plus maze do not appear to be affected in Syap1 knockout mice. KW - Syap1 knockout KW - Motor behaviour KW - Associative learning KW - Fear conditioning KW - Object recognition Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-201986 N1 - PDF includes: Correction: An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance - February 15, 2020. Biology Open (2020) 9, bio048942. doi:10.1242/bio.048942 VL - 8 ER - TY - JOUR A1 - Vollmuth, Christoph A1 - Muljukov, Olga A1 - Abu-Mugheisib, Mazen A1 - Angermeier, Anselm A1 - Barlinn, Jessica A1 - Busetto, Loraine A1 - Grau, Armin J. A1 - Günther, Albrecht A1 - Gumbinger, Christoph A1 - Hubert, Nikolai A1 - Hüttemann, Katrin A1 - Klingner, Carsten A1 - Naumann, Markus A1 - Palm, Frederick A1 - Remi, Jan A1 - Rücker, Viktoria A1 - Schessl, Joachim A1 - Schlachetzki, Felix A1 - Schuppner, Ramona A1 - Schwab, Stefan A1 - Schwartz, Andreas A1 - Trommer, Adrian A1 - Urbanek, Christian A1 - Volbers, Bastian A1 - Weber, Joachim A1 - Wojciechowski, Claudia A1 - Worthmann, Hans A1 - Zickler, Philipp A1 - Heuschmann, Peter U. A1 - Haeusler, Karl Georg A1 - Hubert, Gordian Jan T1 - Impact of the coronavirus disease 2019 pandemic on stroke teleconsultations in Germany in the first half of 2020 JF - European Journal of Neurology N2 - Background and purpose The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany. Methods In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted. Results Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care. Conclusions Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany. KW - COVID-19 KW - SARS-CoV- 2 KW - stroke KW - telemedicine KW - survey Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259396 VL - 28 IS - 10 ER - TY - THES A1 - Tranziska, Ann-Kathrin T1 - Untersuchungen zum molekularen Pathomechanismus der SMA durch Anaylse der Smn-Interaktionspartner hnRNP-R und hnRNP-Q T1 - Research on the pathomechanism of SMA by analysing the Smn interaction partners hnRNP-R and hnRNP-Q N2 - Spinale Muskelatrophie (SMA), die häufigste autosomal rezessive neuromuskuläre Erkrankung bei Kindern und jungen Erwachsenen, wird durch Mutationen in der telomeren Kopie des survival motor neuron (SMN1) Gens auf dem humanen Chromosom 5 verursacht. Anders als bei Mäusen, welche nur ein Smn Gen haben, gibt es beim Menschen eine zweite Kopie (SMN2). Das Genprodukt dieser zweiten Kopie wird am C-Terminus bevorzugt alternativ gespleißt. Es bringt nur eine kleine Menge des vollständigen SMN Proteins hervor. Der Grund, warum eine reduzierte Menge des ubiquitär exprimierten SMN Proteins speziell zu einer Motorneuronendegeneration führt, ohne andere Zelltypen gleichermaßen zu betreffen ist noch immer nicht bekannt. Mit Hilfe der Yeast-Two-Hybrid Technik wurden die beiden heterogenen nukleären Ribonukleoproteine hnRNP-R und hnRNP-Q als neue SMN-bindende Proteine identifiziert. Diese beiden hochhomologen Proteine waren bereits bekannt und stehen in Verbindung mit dem RNA Metabolismus, im Speziellen: Editing, Transport und Spleißing. hnRNP-R und -Q interagieren mit Wildtyp Smn, aber nicht mit trunkierten oder mutierten Smn Formen, welche in SMA-Patienten gefunden wurden. Beide Proteine werden in den meisten Geweben exprimiert. Im Rückenmark von Mäusen ist die stärkste Expression am neunzehnten embryonalen Tag zu beobachten. Interessanterweise ist hnRNP-R hauptsächlich in den Axonen von Motoneuronen zu finden und kolokalisiert dort mit Smn. Im Mausmodell für die SMA konnte gezeigt werden, dass sich die Motoneurone von erkrankten Mäusen hinsichtlich der Morphologie ihrer Neuriten von solchen aus Wildtyp Mäusen unterscheiden. Werden hnRNP-R oder hnRNP-Q in kultivierten Nervenzellen exprimiert, so fördern sie das Wachstum von Neuriten. Bei SMA-Patienten ohne Mutation im SMN Gen konnte allerdings weder Mutation noch Deletion in hnRNP-R oder hnRNP-Q nachgewiesen werden. Die Ergebnisse dieser Arbeit können entscheidend zu einem besseren Verständnis der motoneuronen spezifischen Funktion von Smn bei der SMA beitragen. N2 - Spinal muscular atrophy (SMA), the most common hereditary motor neuron disease in children and young adults is caused by mutations in or loss of the telomeric survival motor neuron (SMN1) gene on human chromosome 5. The human genome, in contrast to mouse, contains a second SMN gene (SMN2) which is transcribed into an mRNA, that is predominantly alternatively spliced at the C-terminus. Therefore, it gives rise to low levels of full-length SMN protein. The reason why reduced levels of the ubiquitously expressed SMN protein lead to specific motor neuron degeneration without affecting other cell types is still not understood. Using yeast two-hybrid techniques, hnRNP-R and the highly related hnRNP-Q were identified as novel SMN interaction partners. These highly homologous proteins were known before in the context of RNA metabolism, in particular: editing, transport and splicing. HnRNP-R and -Q interact with wildtype Smn but not with truncated or mutant Smn forms identified in SMA patients. Both proteins are expressed in most tissues. In the mouse spinal cord the expression peaks at embryonic day nineteen. Interestingly, hnRNP-R is predominantly located in axons of motor neurons where it co-localises with Smn. It could be shown in mouse models for SMA that motor neurons of affected mice differ from wildtype mice in the morphology of their neurites. When hnRNP-R or hnRNP-Q were expressed in neuronal cells they promote neurite outgrowth. However, no mutation or deletion could be found in the genes for hnRNP-R or hnRNP-Q of SMA patients without mutations in the SMN gene. The results of this thesis could help to understand the specific Smn function in motoneurons. KW - Spinale Muskelathropie KW - Genexpression KW - SMA KW - Smn KW - hnRNP-R KW - hnRNP-Q KW - SMA KW - Smn KW - hnRNP-R KW - hnRNP-Q Y1 - 2004 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-8256 ER - TY - THES A1 - Tian, Rui T1 - Structural and functional organization of synaptic proteins in Drosophila melanogaster T1 - Strukturelle und funktionelle Organisation von synaptischen Proteinen in Drosophila melanogaster N2 - Structural and functional modifications of synaptic connections (“synaptic plasticity”) are believed to mediate learning and memory processes. Thus, molecular mechanisms of how synapses assemble in both structural and functional terms are relevant for our understanding of neuronal development as well as the processes of learning and memory. Synapses form by an asymmetric association of highly specialized membrane domains: at the presynaptic active zone transmitter filled vesicles fuse, while transmitter receptors at the opposite postsynaptic density sense this signal. By genetic analysis, matrix proteins of active zones from various families have been shown to be important for fast vesicle fusion, and were suggested to contribute to synapse stability and assembly. The Sigrist lab in collaboration with the Buchner lab previously had shown that the large scaffold protein Bruchpilot (Brp) is essential for both the structural and functional integrity of active zones and for synaptic plasticity in Drosophila melanogaster. The work described in this thesis investigated several candidate proteins which appear to be involved in preand postsynaptic function, as summarized in the following: (1) DREP-2 (DEF45 related protein-2) had been found by co-immunoprecipitations with anti-Brp antibodies by Dr. Manuela Schmidt (unpublished data). Mutants and antibodies for the further study of DREP- 2 were generated in this thesis. Yeast two hybrid results suggest that DREP-2 might interact with dynein light chain 2, while in vivo imaging indicates that DREP-2 might be involved in bidirectional axonal transport. (2) Coimmunoprecipitation and pull down experiments suggested that the ARFGAP [ADP-ribosylation factor (ARF)-directed GTPase activating protein (GAP)] protein GIT (G-protein coupled receptor kinase interacting protein) could interact with the endocytosis associated molecule Stoned B (StnB). Mutants in the dgit gene showed an accumulation of large size vesicles, membrane intermediates and decreased vesicle density at the 3rd instar larval neuromuscular junction (NMJ) by electron microscopy (EM). The phenotypes accumulation of large size vesicles and membrane intermediates could be rescued partially by expression of Drosophila GIT (DGIT) or human GIT in dgit mutant background. Furthermore, by immunofluorescence the dgit mutant shows specifically decreased levels of StnB, which could be restored partially by the expression of DGIT. These results strongly support the suggestion that DGIT interacts with StnB, which is involved in the regulation of vesicle size, endocytosis or recycling of synaptic vesicles (SVs). Furthermore, the dgit mutants also showed signs of a mislocalization of the presynaptic protein Brp relative to the postsynaptic protein GluRIID, which could be rescued by expression of DGIT or human GIT in the dgit mutant background, but not by StnB. These results suggest that GIT on one hand executes roles in the regulation of synaptic vesicle endocytosis, but potentially also has structural roles for synapse assembly (3) Djm-1 is a candidate locus to mediate mental retardation in human patients when it is mutated. As a first step towards an understanding of the mechanistic role of DJM-1, Drosophila genetics were used to address DJM-1 function. So far, however, the djm-1 mutant generated in this thesis did not show a nervous system phenotype. N2 - Es wird angenommen, dass strukturelle und funktionale Änderungen an synaptischen Verbindungen („synaptische Plastizität”) die Grundlage für Lern- und Gedächtnisprozesse darstellen. Daher sind die molekularen Mechanismen des strukturellen und funktionalen Aufbaus von Synapsen wichtig für das Verständnis von neuronaler Entwicklung sowie von Lernund Gedächtnisprozessen. Synapsen werden durch eine asymmetrische Verbindung von zwei hochspezialisierten Membranen gebildet: An der präsynaptischen aktiven Zone fusionieren mit Transmittern gefüllte Vesikel, während Transmitterrezeptoren in der gegenüberliegenden postsynaptischen Dichte dieses Signal wahrnehmen. Durch genetische Analysen wurde gezeigt, dass Matrixproteine der aktiven Zone verschiedener Familien wichtig für die schnelle Vesikelfusion sind. Es wird angenommen, dass diese Proteine zu synaptischer Stabilität und dem Aufbau von Synapsen beitragen. Das Labor von Stephan Sigrist hat in einer Kollaboration mit dem Labor von Erich Buchner in der Vergangenheit gezeigt, dass das große Gerüstprotein Bruchpilot (Brp) essentiell für sowohl die strukturelle und funktionale Intaktheit von aktiven Zonen als auch für synaptische Plastizität in Drosophila melanogaster ist. Im Zuge dieser Doktorarbeit wurden mehrere Kandidatenproteine untersucht, die vermutlich eine Rolle in prä- und postsynaptischer Funktionen spielen, was folgendermaßen zusammengefasst werden kann: 1. DREP-2 (DFF45 related protein 2) wurde von Dr. Manuela Schmidt durch Koimmunpräzipitationen mit Anti-Brp Antikörpern gefunden (unveröffentlichte Daten). Mutanten und Antikörper für die weitere Untersuchung von DREP-2 wurden im Zuge dieser Doktorarbeit erzeugt. Die Ergebnisse aus Hefe-Zwei-Hybrid Versuchen legen nahe, dass DREP- 2 mit Dynein light chain 2 interagieren könnte, während in vivo Bildgebung darauf hindeutet, dass DREP-2 in bidirektionalen axonalen Transport involviert sein könnte. 2. Koimmunpräzipitations- und Pulldown-Experimente ließen den Schluss zu, dass das ARFGAP-Protein (ADP-ribosylation factor (ARF)-directed GTPase activating proteins (GAPs)) GIT (G-protein coupled receptor kinase interacting protein) mit dem mit Endozytose assoziierten Protein Stoned B (StnB) interagieren könnte. Elektronenmikroskopie der neuromuskulären Synapse von Larven im dritten Larvalstadium, die mutant für das dgit-Gen sind, zeigte eine Akkumulation von großen Vesikeln und Membran-Zwischenprodukten sowie eine verringerte Vesikeldichte. Zwei der Phänotypen, die Akkumulation großer Vesikel und der Membran-Zwischenprodukte, konnten durch die Expression von Drosophila GIT (DGIT) oder menschlichem GIT im dgit-mutanten Hintergrund teilweise ausgeglichen werden. Darüberhinaus wurde über Immunofluoreszenz deutlich, dass die dgit-Mutante eine spezifisch reduzierte Menge an StnB enthält, was durch die Expression von DGIT teilweise ausgeglichen werden konnte. Diese Ergebnisse unterstützen die Vorstellung sehr, dass DGIT mit StnB interagiert.. StnB spielt eine Rolle bei der Regulierung von Vesikelgrößen, Endozytose und der Wiederverwertung von synaptischen Vesikeln. Darüberhinaus zeigen dgit Mutanten Hinweise auf eine fehlerhafte Lokalisierung des präsynaptischen Proteins Brp relativ zu dem postsynaptischen Protein GluRIID, was furch die Expression von DGIT oder menschlichem GIT im dgit-mutanten Hintergrund ausgeglichen werden konnte, nicht jedoch durch StnB. Diese Ergebnisse legen den Schluss nahe, dass GIT einerseits eine Rolle bei der Regulierung der Endozytose synaptischer Vesikel spielt aber möglicherweise auch eine strukturelle Funktion beim Aufbau von Synapsen hat. 3. Djm-1 ist ein genetischer Lokus, der geistige Behinderung bei menschlichen Patienten hervorruft, wenn er mutiert vorliegt. Als ersten Schritt in Richtung eines Verständnisses der mechanistischen Rolle von DJM-1, wurde Genetik in Drosophila durchgeführt, um die Funktion von DJM-1 zu untersuchen. Die in dieser Doktorarbeit erzeugte djm-1 Mutante zeigte jedoch bisher keinen anomalen Phänotyp im Nervensystem. KW - Taufliege KW - Synaptische Transmission KW - Proteine KW - synaptisches Protein KW - Drosophila melanogaster KW - Drosophila melanogaster KW - synaptic proteins Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-57399 ER - TY - JOUR A1 - Thoenen, Hans A1 - Hughes, Richard A. A1 - Sendtner, Michael T1 - Trophic support of motoneurons: physiological, pathophysiological, and therapeutic implications. N2 - No abstract available Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31746 ER - TY - CHAP A1 - Thoenen, Hans A1 - Hughes, Richard A. A1 - Sendtner, Michael T1 - Towards a comprehensive understanding of the trophic support of motoneurons N2 - Motoneurons played an essential role in establishing the concept of target-mediated support of innervating neurons. However, it took several decades until molecules were identined which trophically support motoneurons in vitro and in vivo. The most potent molecule identined so far is ciliary neurotrophic factor (CNTF). It is expressed as a cytosolic molecule in myelinating Schwann cells rather than in skeletal muscle in the postnatal period and therefore does not qualify as a target-derived neurotrophic factor regulating motoneuron survival during embryonic development. However, the inactivation of CNTF by gene targeting experiments results in progressive atrophy and degeneration of motoneurons, demonstrating that CNTF plays an essential role as a maintenance factor for motoneurons postnatally. Secretory molecules which are expressed in skeletal muscle during embryonic development and which support motoneurons in culture and partially also in vivo include members of the NGF gene family (BDNF, NT-3, NT-4/S) , FGF-S, IGF-I, and UF. The evaluation of the physiological importance of these molecules is under investigation. KW - neurotrophic molecules KW - CNTF KW - gene targeting KW - NGF gene family KW - FGF-5 KW - lIF KW - IGF-I Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31117 ER - TY - THES A1 - Thangaraj Selvaraj, Bhuvaneish T1 - Role of CNTF-STAT3 signaling for microtubule dynamics inaxon growth and maintenance: Implications in motoneuron diseases T1 - Die Funktion des CNTF-STAT3 Signalweges für die Microtubuli Dynamik in Axonalem Wachstum und Axon Erhalt: Implikationen für Motoneuronenerkrankungen N2 - Neurotrophic factor signaling modulates differentiation, axon growth and maintenance, synaptic plasticity and regeneration of neurons after injury. Ciliary neurotrophic factor (CNTF), a Schwann cell derived neurotrophic factor, has an exclusive role in axon maintenance, sprouting and synaptic preservation. CNTF, but not GDNF, has been shown to alleviate motoneuron degeneration in pmn mutant mice carrying a missense mutation in Tbce gene, a model for Amyotrophic Lateral Sclerosis (ALS). This current study elucidates the distinct signaling mechanism by which CNTF rescues the axonal degeneration in pmn mutant mice. ... N2 - Neurotrophe Faktoren beeinflussendie die neuronale Differenzierung, das Wachstum und die Stabilisierung von Axonen sowie Synaptische Plastizität und die Regeneration von Neuronen nach Verletzung. Der von Schwannzellen synthetisierte neurotrophe Faktor Ciliary neurotrophic factor (CNTF) spielt eine wichtige Rolle bei der axonalen Erhaltung sowie bei der Induktion und Reduktion von axonalen Verzweigungen. Die Behandlung der pmn Mausmutante mit CNTF, aber nicht mit GDNF führt zu einem späteren Krankheitsbeginn und verminderten Fortschreiten der Motoneuronendegeneration. Diese Mausmutante, die eine Punktmutation im Tbce Gen trägt, dient als Modell für die Amyotrophe Lateralsklerose. Ziel der vorliegenden Arbeit war es, die zugrunde liegenden Signalkaskaden aufzudecken, die den CNTF-vermittelten Effekt auf den Krnakheitsverlauf bei der pmn Maus verursachen. ... KW - Ciliary neurotrophic factor KW - STAT KW - CNTF KW - STAT3 KW - Stathmin KW - Microtubules KW - Signaltransduktion KW - Motoneuron KW - Krankheit Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-76889 ER - TY - JOUR A1 - Tejero, Rocio A1 - Alsakkal, Mohammad A1 - Hennlein, Luisa A1 - Lopez-Cabello, Ana M. A1 - Jablonka, Sibylle A1 - Tabares, Lucia T1 - Nifedipine ameliorates cellular differentiation defects of Smn-deficient motor neurons and enhances neuromuscular transmission in SMA mice JF - International Journal of Molecular Sciences N2 - In spinal muscular atrophy (SMA), mutations in or loss of the Survival Motor Neuron 1 (SMN1) gene reduce full-length SMN protein levels, which leads to the degeneration of a percentage of motor neurons. In mouse models of SMA, the development and maintenance of spinal motor neurons and the neuromuscular junction (NMJ) function are altered. Since nifedipine is known to be neuroprotective and increases neurotransmission in nerve terminals, we investigated its effects on cultured spinal cord motor neurons and motor nerve terminals of control and SMA mice. We found that application of nifedipine increased the frequency of spontaneous Ca\(^{2+}\) transients, growth cone size, cluster-like formations of Cav2.2 channels, and it normalized axon extension in SMA neurons in culture. At the NMJ, nifedipine significantly increased evoked and spontaneous release at low-frequency stimulation in both genotypes. High-strength stimulation revealed that nifedipine increased the size of the readily releasable pool (RRP) of vesicles in control but not SMA mice. These findings provide experimental evidence about the ability of nifedipine to prevent the appearance of developmental defects in SMA embryonic motor neurons in culture and reveal to which extent nifedipine could still increase neurotransmission at the NMJ in SMA mice under different functional demands. KW - spinal muscular atrophy KW - motor neurons KW - synaptic transmission KW - neuromuscular junction KW - calcium channels KW - nifedipine KW - growth cone KW - axons KW - synaptic vesicles KW - postsynaptic potentials Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-313636 SN - 1422-0067 VL - 24 IS - 8 ER - TY - JOUR A1 - Stöckli, K. A. A1 - Lottspeich, F. A1 - Sendtner, Michael A1 - Masiakowski, P. A1 - Carroll, Patrick A1 - Götz, Rudolf A1 - Lindholm, D. A1 - Thoenen, Hans T1 - Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor N2 - CILIARY neurotrophic factor (CNTF) was originally characterized as a survival factor for chick ciliary neurons in vitro. More recently, it was shown to promote the survival of a variety of otherneuronal cell types and to affect the differentiation of E7 chick sympathetic neurons by inhibiting their proliferation and by inducing the expression of yasoactiYe intestinal peptide immunoreactiyity (VIP-IR). In cultures of dissociated sympathetic neurons from newborn rats, CNTF induces cholinergic differentiation as shown by increased levels of choline acetyltransferase (ChAT. Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-34229 ER - TY - JOUR A1 - Stöckli, K. A. A1 - Lililien, L. E. A1 - Näher- Noé, M. A1 - Breitfeld, G. A1 - Hughes, Richard A. A1 - Raff, M. C. A1 - Thoenen, Hans A1 - Sendtner, Michael T1 - Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain N2 - Ciliary neurotrophic factor (CNTF) is a potent survival molecule for a variety of embryonic neurons in culture. The developmental expression of CNTF occurs clearly after the time period of the physiological cell death of CNTF-responsive neurons. This, together with the sites of expression, excludes CNTF as a target-derived neuronal survival factor, at least in rodents. However, CNTF also participates in the induction of type 2 astrocyte differentiation in vitro. Here we demonstrate that the time course of the expression of CNTF-mRNA and protein in the rat optic nerve (as evaluated by quantitative Northern blot analysis and biological activity, respectively) is compatible with such a glial differentiation function of CNTF in vivo. We also show that the type 2 astrocyte-inducing- activity previously demonstrated in optic nerve extract can be precipitated by an antiserum against CNTF. Immunohistochemical analysis of astrocytes in vitro and in vivo demonstrates that the expression of CNTF is confined to a subpopulation of type 1 astrocytes. The olfactory bulb of adult rats has comparably high levels of CNTF to the optic nerve, and here again, CNTF-immunoreactivity is localized in a subpopulation of astrocytes. However, the postnatal expression of CNTF in the olfactory bulb occurs later than in the optic nerve. In other brain regions both CNTF-mRNA and protein levels are much lower. Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31172 ER - TY - JOUR A1 - Stengel, Helena A1 - Vural, Atay A1 - Brunder, Anna-Michelle A1 - Heinius, Annika A1 - Appeltshauser, Luise A1 - Fiebig, Bianca A1 - Giese, Florian A1 - Dresel, Christian A1 - Papagianni, Aikaterini A1 - Birklein, Frank A1 - Weis, Joachim A1 - Huchtemann, Tessa A1 - Schmidt, Christian A1 - Körtvelyessy, Peter A1 - Villmann, Carmen A1 - Meinl, Edgar A1 - Sommer, Claudia A1 - Leypoldt, Frank A1 - Doppler, Kathrin T1 - Anti–pan-neurofascin IgG3 as a marker of fulminant autoimmune neuropathy JF - Neurology: Neuroimmunology & Neuroinflammation N2 - Objective To identify and characterize patients with autoantibodies against different neurofascin (NF) isoforms. Methods Screening of a large cohort of patient sera for anti-NF autoantibodies by ELISA and further characterization by cell-based assays, epitope mapping, and complement binding assays. Results Two different clinical phenotypes became apparent in this study: The well-known clinical picture of subacute-onset severe sensorimotor neuropathy with tremor that is known to be associated with IgG4 autoantibodies against the paranodal isoform NF-155 was found in 2 patients. The second phenotype with a dramatic course of disease with tetraplegia and almost locked-in syndrome was associated with IgG3 autoantibodies against nodal and paranodal isoforms of NF in 3 patients. The epitope against which these autoantibodies were directed in this second phenotype was the common Ig domain found in all 3 NF isoforms. In contrast, anti–NF-155 IgG4 were directed against the NF-155–specific Fn3Fn4 domain. The description of a second phenotype of anti–NF-associated neuropathy is in line with some case reports of similar patients that were published in the last year. Conclusions Our results indicate that anti–pan-NF-associated neuropathy differs from anti–NF-155-associated neuropathy, and epitope and subclass play a major role in the pathogenesis and severity of anti–NF-associated neuropathy and should be determined to correctly classify patients, also in respect to possible differences in therapeutic response. KW - neurology Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-202462 VL - 6 IS - 5 ER - TY - THES A1 - Simon, Christian Marc T1 - Effects of the neurotrophic factors CNTF and IGF-1 in mouse models for spinal muscular atrophy and diabetic neuropathy T1 - Effekte der neurotrophen Faktoren CNTF und IGF-1 in Mausmodellen für spinale Muskelatrophie und diabetische Neuropathie N2 - In this study I investigate the role of Schwann cell and axon-derived trophic signals as modifiers of axonal integrity and sprouting in motoneuron disease and diabetic neuropathy (DNP). The first part of this thesis focuses on the role of the Schwann-cell-derived ciliary neurotrophic factor (CNTF) for compensatory sprouting in a mouse model for mild spinal muscular atrophy (SMA). In the second part, the role of the insulin-like growth factor 1 (IGF-1) and its binding protein 5 (IGFBP-5) is examined in the peripheral nerves of patients with DNP and in two corresponding mouse models. Proximal SMA is caused by homozygous loss or mutation of the SMN1 gene on human chromosome 5. The different forms of SMA can be divided into four groups, depending on the levels of SMN protein produced from a second SMN gene (SMN2) and the severity of the disease. Patients with milder forms of the disease, type III and type IV SMA, normally reach adulthood and regularly show enlargement of motor units, signifying the reinnervation of denervated muscle fibers. However, the underlying mechanisms are not understood. Smn+/- mice, a model of type III/IV SMA, are phenotypically normal, but they reveal progressive loss of motor neurons and denervation of motor endplates starting at 4 weeks of age. The progressive loss of spinal motor neurons reaches 50% at 12 months but muscle strength is not reduced. The first evidence for axonal sprouting as a compensatory mechanism in these animals was the more than 2-fold increase in amplitude of single motor unit action potentials (SMUAP) in the gastrocnemius muscle. Confocal analysis confirmed pronounced sprouting of innervating motor axons. As CNTF is highly expressed in Schwann cells and known to be involved in sprouting, its role for this compensatory sprouting response and the maintenance of muscle strength in Smn+/- mice was investigated. Deletion of CNTF in this mouse model results in reduced sprouting and decline of muscle strength in Smn+/- Cntf-/- mice. These findings indicate that CNTF is necessary for a sprouting response and thus enhances the size of motor units in skeletal muscles of Smn+/- mice. DNP afflicting motor and sensory nerve fibers is a major complication in diabetes mellitus. The underlying cellular mechanisms of motor axon degeneration are poorly understood. IGFBP-5, an inhibitory binding protein for IGF-1, is highly upregulated in peripheral nerves in patients with DNP. The study investigates the pathogenic relevance of this finding in transgenic mice overexpressing IGFBP-5 in motor axons. These mice develop motor axonopathy similar to that seen in DNP. Motor axon degeneration is also observed in mice in which the IGF-1 receptor (IGF-1R) was conditionally depleted in motoneurons, indicating that reduced activity of IGF-1 on IGF-1R in motoneurons is responsible for the observed effect. These data provide evidence that elevated expression of IGFBP-5 in diabetic nerves reduces the availability of IGF-1 for IGF-1R on motor axons leading to progressive neurodegeneration, and thus offers novel treatment strategies. N2 - In dieser Arbeit habe ich die Rolle der neurotrophen Faktoren Ciliary neurotrophic factor (CNTF) und Insulin-like-growth factor 1 (IGF-1), die in Schwannzellen gebildet werden, als Modulatoren der axonalen Integrität bei einer degenerativen Motoneuronenerkrankung und bei diabetischer Neuropathie (DNP) untersucht. Im ersten Teil dieser Arbeit wird gezeigt, dass CNTF für ein kompensatorisches Sprouting von motorischen Axonen in einem Mausmodell für spinale Muskelatrophie (SMA) verantwortlich ist. Im zweiten Teil wird die Rolle von IGF-1 und dessen Bindeprotein, IGFBP-5, in Axonen motorischer Nerven bei Patienten mit DNP und zwei korrespondieren Mausmodellen gezeigt. Die proximale SMA wird durch einen homozygoten Verlust oder Mutation des SMN1 Gens auf dem Chromosom 5 verursacht. Bei der spinalen Muskelatrophie unterscheidet man verschiedene Schweregrade, abhängig von der Menge an SMN Protein, das vom zweiten SMN Gen (SMN2) produziert werden kann. Patienten mit einer milderen Form von SMA (Typ III und IV) erreichen das Erwachsenenalter und zeigen oft vergrößerte motorische Einheiten, im Gegensatz zu Patienten mit den schweren kindlichen Formen der Erkrankung. Smn+/- Mäuse, ein Modell für die leichten SMA Formen Typ II und IV, zeigen denervierte Endplatten bereits 4 Wochen nach der Geburt und einen fortschreitenden Verlust von Motoneuronen, der nach 12 Monaten mehr als 50% beträgt, ohne dass sich die Muskelkraft der Tiere verringert. Die Amplitude der Summenpotenziale von einzelnen motorischen Einheiten (Single motor unit action potential, SMUAP) im Wadenmuskel ist mehr als 2-fach erhöht. Konfokale Aufnahmen bestätigen ausgeprägtes Sprouting der noch innervierenden Axone. Smn+/- Mäuse ohne CNTF, das normalerweise stark in Schwann-Zellen exprimiert ist, zeigen reduziertes Sprouting und verringerte Muskelkraft. Diese Ergebnisse sprechen dafür, dass CNTF für das Sprouting und die vergrößerten motorischen Einheiten in Smn+/- Mäusen verantwortlich ist. Dieser kompensatorische Mechanismus könnte neue Behandlungs-möglichkeiten für Motoneuronerkrankungen eröffnen. Die Diabetische Neuropathie (DNP), eine der Hauptkomplikationen bei Diabetes Mellitus, betrifft sowohl motorische als auch sensorische Nervenfasern. Die zugrunde liegenden zellulären Mechanismen, die zur Degeneration motorischer Axone in Spätstadien der Erkrankung führen, sind größtenteils noch ungeklärt. IGFBP-5, ein IGF-1 hemmendes Bindeprotein, ist in peripheren Nervbiopsien von DNP Patienten stark überexprimiert. Diese potenzielle pathogene Relevanz wurde bei IGFBP-5 überexprimierenden transgenen Mäusen untersucht. Diese Mäuse entwickeln ähnlich wie die DNP Patienten eine motorische Axonopathie. Diese Axondegeneration zeigen auch Mäuse, bei denen der IGF-1 Rezeptor (IGF-1R) neuronenspezifisch ausgeschaltet wurde. Das bedeutet, dass reduzierte Wirkung von IGF-1 am IGF-1R auf Axonen von Motoneuronen für die beobachtete Axonopathie verantwortlich ist. Zusammenfassend zeigen diese Daten, dass erhöhtes IGFBP-5 in diabetischen Nerven die Verfügbarkeit von IGF-1 für den IGF-1R reduziert und zu progressiver Neurodegeneration führt. Diese Erkenntnis könnte neue Behandlungsstrategien für Patienten mit DNP eröffnen. KW - Spinale Muskelatrophie KW - Ciliary neurotrophic factor KW - Insulin-like-Growth-Factor-Binding-Protein-5 KW - Diabetische Polyneuropathie KW - Insulin-like Growth KW - Spinal muscular atrophy KW - Ciliary neurotrophic factor KW - Insulin-like-Growth-Factor-Binding-Protein-5 KW - Diabetic polyneuropathy Y1 - 2011 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-70207 ER - TY - JOUR A1 - Sendtner, Michael A1 - Thoenen, Hans A1 - Hughes, R. A. T1 - Members of several gene families influence survival of rat motoneurons in vitro and in vivo N2 - The survival and functional maintenance of spinal motoneurons, both during the period of developmental cell death and in adulthood, have been shown to be dependent on trophic factors. In vitro experiments have previously been used to identify several survival factors for motoneurons, including CNTF, UF, and members of the neurotrophin, FGF, and IGF gene families. Some of these factors have also been shown to be active in vivo, either on chick motoneurons during embryonic development or on lesioned facial and spinal motoneurons of the newborn rat. Here we demonstrate that lesioned newborn rat facial motoneurons can be rescued by NT-4/5, IGF-I, and UF. Furthermore, in contrast to chick motoneurons, the survival of isolated embryonic rat motoneurons can be maintained by the neurotrophins BDNF, NT-3, and NT-4/5. IGF-I and FGF-5 were also active in this system, each supporting more than 50% of the originally plated neurons. The responsiveness of motoneurons to multiple factors in vitro and in vivo suggests that motoneuron survival and function are regulated by the coordinated actions of members of different gene families. KW - Immunopanning KW - Facial Nerve Transection KW - Neurotrophin KW - Fibroblast Growth Factor KW - Insulinlike Growth Factor Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42652 ER - TY - JOUR A1 - Sendtner, Michael A1 - Thoenen, Hans A1 - Holtmann, B. A1 - Kohlbeck, R. A1 - Barde, Y.-A. T1 - Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section N2 - Motoneurons innervating the skeletal musculature were among the first neurons shown to require the presence of their target cells to develop appropriatelyl,2. But the characterization of molecules allowing motoneuron survival has been difficult. Ciliary neurotrophic factor prevents the death of motoneurons3-6, but its gene is not expressed during development7. Although the presence of a neurotrophin receptor on developing motoneurons8-1O has suggested a role for neurotrophins, none could be shown to promote motoneuron survival in vitro3. We report here that brainderived neurotrophic factor can prevent the death of axotomized motoneurons in newborn rats, suggesting a role for this neurotrophin for motoneuron survival in vivo. Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42673 ER - TY - JOUR A1 - Sendtner, Michael A1 - Thoenen, Hans T1 - Oxidative stress and motorneuron disease N2 - Transgenic mice carrying mutated Cu/Zn superoxide dismutase genes provide insights into the pathogenesis of human motorneuron diseases and may be useful as models in the development and testing of therapies. Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42684 ER - TY - JOUR A1 - Sendtner, Michael A1 - Stöckli, Kurt A. A1 - Thoenen, Hans A1 - Schmalbruch, H. A1 - Carroll, P. A1 - Kreutzberg, Georg W. T1 - Ciliary neurotrophic factor prevents the degeneration of motor neurons in mouse mutant progressive motor neuronopathy N2 - CILIARY neurotrophic factor (CNTF) supports the survival of embryonic motor neurons in vitro and in vivo and prevents lesion-mediated degeneration of rat motor neuron~ during early post-natal stages. Here we report that CNTF greatly reduces all the functional and morphological changes in pmnlpmn mice5, an autosomal recessive mutant leading to progressive caudo-cranial motor neuron degeneration. The first manifestations of progressive motor neuronopathy in homozygous pmnl pmn mice become apparent in the hind limbs at the end of the third post-natal week and all the mice die up to 6 or 7 weeks after birth from respiratory paralysis. Treatment with CNTF prolongs- survival- and greatly Impoves motor function of these mice. Moreover, morphological manifestations, such as loss of motor axons in the phrenic nerve and degeneration of facial motor neurons, were greatly reduced by CNTF, although the treatment did not start until the first symptoms of the disease had already become apparent and substantial degenerative changes were already present. The protective and restorative effects of CNTF in this mouse mutant give new perspectives for the treatment of human degenerative motor neuron diseases with CNTF. Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42563 ER - TY - JOUR A1 - Sendtner, Michael A1 - Stöckli, Kurt A. A1 - Carroll, Patrick A1 - Kreutzberg, Georg W. A1 - Thoenen, Hans T1 - More on motor neurons N2 - No abstract available Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42598 ER - TY - JOUR A1 - Sendtner, Michael A1 - Stöckli, K. A. A1 - Thoenen, Hans T1 - Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration N2 - Ciliary neurotrophic factor (CNTF) is expressed in high quantities in Schwann cells of peripheral nerves during postnatal development of the rat. The absence of a hydrophobic leader sequence and the immunohistochemical localization of CNTF within the cytoplasm of these cells indicate that the factor might not be available to responsive neurons under physiological conditions. However, CNTF supports the survival of a variety of embryonic neurons, including spinal motoneurons in culture. Moreover we have recently demonstrated that the exogenous application of CNTF protein to the lesioned facial nerve of the newborn rat rescued these motoneurons from cell death. These results indicate that CNTF might indeed play a major role in assisting the survival of lesioned neurons in the adult peripheral nervous system. Here we demonstrate that the CNTF mRNA and protein levels and the manner in which they are regulated are compatible with such a function in lesioned peripheral neurons. In particular, immunohistochemical analysis showed significant quantities of CNTF at extracellular sites after sciatic nerve lesion. Western blots and determination of CNTF biological activity of the same nerve segments indicate that extracellular CNTF seems to be biologically active. After nerve lesion CNTF mRNA levels were reduced to <5 % in distal regions of the sciatic nerve whereas CNTF bioactivity decreased to only one third of the original before-lesion levels. A gradual reincrease in Schwann cells occurred concomitant with regeneration. Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31738 ER - TY - JOUR A1 - Sendtner, Michael A1 - Kreutzberg, Georg W. A1 - Thoenen, Hans T1 - Ciliary neurotrophic factor (CNTF) prevents the degeneration of motor neurons after axotomy N2 - The period of natural cell death in the development of rodent motor neurons is followed by a period of sensitivity to axonal injury1-3. In the rat this early postnatal period of vulnerability coincides with that of very low ciliary neurotrophic factor (CNTF) levels in the sciatic nerve before CNTF increases to the high, adult levels4. The developmental time course of CNTF expression, its regional tissue distribution and its cytosolic localization (as suggested by its primary structure)4*5 favour a role for CNTF as a lesion factor rather than a target-derived neurotrophic molecule like nerve growth factor. Nevertheless CNTF exhibits neurotrophic activity in vitro on different populations of embryonic neurons6. To determine whether the vulnerability of motor neurons to axotomy in the early postnatal phase is due to insufficient availability of CNTF, we transected the axons of newborn rat motor neurons and demonstrated that iocal application of CNTF prevents the degeneration of the corresponding cell bodies. Y1 - 1990 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-32637 ER - TY - RPRT A1 - Sendtner, Michael A1 - Kreutzberg, Georg W. A1 - Jennekens, Frans G. T1 - Workshop on trophic factors in the peripheral nervous system. Capri, October 1991. N2 - No abstract available Y1 - 1992 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31451 ER - TY - JOUR A1 - Sendtner, Michael A1 - Gnahn, H. A1 - Wakade, A. A1 - Thoenen, Hans T1 - Is activation of the Na\(^+\)K\(^+\) pump necessary for NGF-mediated neuronal survival? N2 - The ability of nerve growth factor to cause rapid activation of the Na+K+ pump of its responsive cells was examined by measuring the uptake of 86Rb+. A significant increase in 86Rb+ uptake in Ea chick dorsal root ganglion sensory neurons after NGF treatment was seen only if the cells had been damaged during the preparation procedure. Such damaged cells could not survive in culture in the presence of NGF, and undamaged cells that did survive in response to NGF exhibited no increased 86Rb+ uptake rate. Furthermore, cultured calf adrenal medullary cells did not show an increase in 86Rb+ uptake after treatment with NGF, although these cells respond to NGF with an increased synthesis of catecholaminergic enzymes. These results are incompatible with the hypothesis that the mechanism of action of NGF that promotes neuronal survival and enzyme induction results from an initial stimulation of the Na+K+ pump. Y1 - 1988 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42610 ER - TY - JOUR A1 - Sendtner, Michael A1 - Dittrich, F. A1 - Hughes, R. A. A1 - Thoenen, H. T1 - Actions of CNTF and neurotrophins on degenerating motoneurons : preclinical studies and clinical implications N2 - Spinal motoneurons innervating skeletal muscle were amongst the first neurons shown to require the presence of their target cells to develop appropriately. Isolated embryonie chick and rat motoneurons have been used to identify neurotrophic factors and cytokines capable of supporting the survival of developing motoneurons. Such factors include ciliary neurotrophic factor (CNTF), which is present physiologically in high amounts in myelinating Schwann cells of peripheral nerves, and brain-derived neurotrophic factor (BDNF) which is synthesized in skeletal muscle and, after peripheral nerve lesion. in Schwann cells. These factors have been further analyzed for their physiological significance in maintaining motoneuron function in vivo, and for their potential therapeutic usefulness in degenerative motoneuron disease. Both CNTF and BDNF are capable of rescuing injured facial motoneurons in newbom rats. Furthermore, CNTF prolongs survival and improves motor function of pmn mice, an animal model for degenerative motoneuron disease, by preventing degeneration of motoneuron axons and somata. Thus treatment of human motoneuron disease with neurotrophic factors should be possible, provided that rational means for application of these factors can be established considering also the appearance of potential side effects. KW - Neurobiologie KW - Motor neuron disease; Ciliary neurotrophic factor; Brain-derived neurotrophic factor; Animal models; Neurotrophic factors Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-62939 ER - TY - JOUR A1 - Sendtner, Michael A1 - Carroll, P. A1 - Holtmann, B A1 - Hughes, R. A. A1 - Thoenen, H. T1 - Ciliary Neurotrophic Factor N2 - No abstract available KW - ciliary neuron KW - ciliary neurotrophic factor KW - motoneuron KW - nonneuronaI cells KW - homologous recombination Y1 - 1994 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-42545 ER - TY - JOUR A1 - Sendtner, Michael A1 - Arakawa, Yoshihiro A1 - Stöckli, Kurt A. A1 - Kreutzberg, Georg W. A1 - Thoenen, Hans T1 - Effect of ciliary neurotrophic factor (CNTF) on motoneuron survival N2 - We have demonstrated that the extensive degeneration of motoneurons in the rat facial nucleus after transection of the facial nerve in newborn rats can be prevented by local ciliary neurotrophic factor (CNTF) administration. CNTF differs distinctly from known neurotrophic molecules such as NGF, BDNF and NT-3 in both its molecular characteristics (CNTF is a cytosolic rather than a secretory molecule) and its broad spectrum of biological activities. CNTF is expressed selectively by Schwann cells and astrocytes of the peripheral and central nervous system, respectively, but not by target tissues of the great variety of CNTF -responsive neurons. CNTF mRNA is not detectable by Northern blot or PCR analysis during embryonic development and immediately after birth. However, during the second post-natal week, a more than 30-fold increase in CNTF mRNA and pro tein occurs in the sciatic nerve. Since the period of low CNTF levels in peripheral nerves coincides with that of high vulnerability of motoneurons (i.e. axonallesion results in degeneration of motoneuron cell bodies), insufficient availability of CNTF may be the reason for the rate of lesioninduced cell death of early post-natal motoneurons. Highly enriched embryonic chick motoneurons in culture are supported at survival rates higher than 60% by CNTF, even in single cell cultures, indicating that CNTF acts directly on motoneurons. In contrast to CNTF, the members of the neurotrophin gene family (NGF, BDNF and NT-3) do not support the survival of motoneurons in culture. However, aFGF and bFGF show distinct survival activities which are additive to those of CNTF, resulting in the survival of virtually all motoneurons cultured in the presence of CNTF and bFGF. KW - motoneurons KW - ciliary neurotrophic factor KW - CNTF KW - nerve lesion KW - rat KW - chick KW - neurotrophic factor Y1 - 1991 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-33048 ER - TY - JOUR A1 - Sendtner, Michael T1 - Neurotrophic factors and their action on motoneuron survival: Implications for neuromuscular disorders N2 - Motoneuron diseases represent a m&jor challenge to modern neurology, yet their clinical manifestations ware first described more than hundred years ago, and despite many studies the etiology of these diseases ramd,ns obscure with no effective treatments having been reported. Although progress has been made in establishing genetic linkage in the rare inherited for.ms of these diseases such as familial amyotrophic lateral scleriosisl , spinal mDscular atrophy and X-linked bulbo-spinal-mDscular atrophy, this new information has not yet affected therapeutic techniques. During the last few years several important steps have been taken concerning the physiological mechanisms involved in motoneuron survival during development, after lesion and in animal models of degenerative diseases, the molecular clOning of several new neurotrophic factors (brain-derived neurotrophic factor (BDNP), neurotrophin-3 and-4 (NT-3 and NT-4) and ciliary neurotrophic factor (CNTP)); the identification of a gene family of receptor molecules for same of these factors, progress in the understanding of the effects of polypeptide growth factors on muscle cell differentiation, neuronal sprouting (insulin-like growth factor-I and -11 (IGF-I and IGF-II), and in vitro motoneuronal survival (CNTF, IGF-I and -II and basic FGF). These findings have raised new hopes in that they could lead to a better understanding of the pathophysiological processes underlying these diseases, and that the pharmacological use of same of these newly characterized neurotrophic factors could present new possibilities for the treatment of these diseases. Y1 - 1993 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-31149 ER - TY - THES A1 - Segebarth, Dennis T1 - Evaluation and validation of deep learning strategies for bioimage analyses T1 - Evaluation und Validierung von Deep learning Strategien für die Analyse biologischer Bilddaten N2 - Significant advances in fluorescence imaging techniques enable life scientists today to gain insights into biological systems at an unprecedented scale. The interpretation of image features in such bioimage datasets and their subsequent quantitative analysis is referred to as bioimage analysis. A substantial proportion of bioimage analyses is still performed manually by a human expert - a tedious process that is long known to be subjective. Particularly in tasks that require the annotation of image features with a low signal-to-noise ratio, like in fluorescence images of tissue samples, the inter-rater agreement drops. However, like any other scientific analysis, also bioimage analysis has to meet the general quality criteria of quantitative research, which are objectivity, reliability, and validity. Thus, the automation of bioimage analysis with computer-aided approaches is highly desirable. Albeit conventional hard-coded algorithms are fully unbiased, a human user has to set its respective feature extraction parameters. Thus, also these approaches can be considered subjective. Recently, deep learning (DL) has enabled impressive advances in computer vision research. The predominant difference between DL and conventional algorithms is the capability of DL models to learn the respective task on base of an annotated training dataset, instead of following user-defined rules for feature extraction. This thesis hypothesized that DL can be used to increase the objectivity, reliability, and validity of bioimage analyses, thus going beyond mere automation. However, in absence of ground truth annotations, DL models have to be trained on manual and thus subjective annotations, which could cause the model to incorporate such a bias. Moreover, model training is stochastic and even training on the same data could result in models with divergent outputs. Consequently, both the training on subjective annotations and the model-to-model variability could impair the quality of DL-based bioimage analyses. This thesis systematically assessed the impacts of these two limitations experimentally by analyzing fluorescence signals of a protein called cFOS in mouse brain sections. Since the abundance of cFOS correlates with mouse behavior, behavioral analyses could be used for cross-validation of the bioimage analysis results. Furthermore, this thesis showed that pooling the input of multiple human experts during model training and integration of multiple trained models in a model ensemble can mitigate the impact of these limitations. In summary, the present study establishes guidelines for how DL can be used to increase the general quality of bioimage analyses. N2 - Fortschritte in den Methoden der fluoreszenz-basierten Bildgebung ermöglichen Biowissenschaftlern heutzutage noch nie dagewesene Einblicke in biologische Systeme. Die Interpretation sowie die anschließende quantitative Analyse von Bildelementen in biologischen Bilddatensätzen wird in der Wissenschaft als bioimage analysis bezeichnet. Ein wesentlicher Anteil der bioimage analysis wird noch immer von Experten per Hand durchgeführt - ein mühsamer Prozess, von dem man seit langem weiß, dass er subjektiv ist. Besonders bei Aufgabestellungen, welche die Annotierung von Bildelementen mit einem geringen Signal-Rausch-Verhältnis erfordern, wie es beispielsweise bei Fluoreszenzbildern von Gewebeproben der Fall ist, sinkt die Übereinstimmung zwischen den Bewertungen mehrerer Experten. Genauso wie jede andere wissenschaftliche Analyse, muss jedoch auch die bioimage analysis den generellen Qualitätskriterien quantitativer Forschung gerecht werden. Dies sind Objektivität, Zuverlässigkeit und Validität. Die Automatisierung der bioimage analysis mit Hilfe von computer-basierten Ansätzen ist somit erstrebenswert. Konventionelle, hartkodierte Algorithmen sind zwar vollkommen unvoreingenommen, jedoch legt ein menschlicher Benutzer jene Parameter fest, die der Algorithmus für die Extraktion der relevanten Bildelemente nutzt. Aus diesem Grund sind auch diese Ansätze zumindest partiell subjektiv. In den letzten Jahren hat Deep learning (DL) zu beeindruckenden Fortschritten auf dem Forschungsgebiet der computer vision beigetragen. Der vorherrschende Unterschied zwischen DL und konventionellen Algorithmen besteht darin, dass DL Modelle in der Lage sind die jeweilige Aufgabe auf Grundlage eines annotierten Trainingsdatensatzes zu lernen, anstatt starr den Parametern zu folgen, die der Benutzer für die Extraktion der relevanten Bildelemente vorgegeben hat. In dieser Dissertation wurde die Hypothese untersucht, ob DL, neben der Möglichkeit der automatischen Bildanalyse, auch dazu genutzt werden kann die Objektivität, die Zuverlässigkeit und die Validität der Bildanalyse zu verbessern. Ohne eine objektive Referenzannotierung muss das Training der DL Modelle jedoch auf händisch erstellten und somit also subjektiven Annotierungen durchgeführt werden. Theoretisch könnte dies dazu führen, dass das DL-Modell diese Vorgeingenommenheit übernimmt. Außerdem unterliegt das Training der Modelle stochastischen Prozessen und selbst Modelle, die auf den gleichen Trainingsdaten trainiert wurden, könnten sich danach in ihren ausgegeben Analysen unterscheiden. Demzufolge könnten also sowohl das Training auf subjektiven Annotierungen als auch die Variabilität von Modell zu Modell die Qualität der DL-basierten Analyse von biologischen Bilddaten beeinträchtigen. In dieser Dissertation werden die Einflüsse von diesen beiden Limitierungen auf Grundlage von experimentellen Daten untersucht. In den experimentellen Bilddaten werden Fluoreszenzsignale des Proteins cFOS in Hirnschnitten von Mäusen dargestellt und hier repräsentativ untersucht. Da das Vorkommen von cFOS mit dem Verhalten der Mäuse korreliert, kann die Analyse des Verhaltens der Mäuse zur Kreuzvalidierung der Analyse der biologischen Bilddaten herangezogen werden. Die Daten dieser Dissertation zeigen, dass die Integration mehrerer Experten in das Training eines Modells sowie die Integration mehrerer trainierter Modelle in ein Modell-Ensemble das Risiko einer subjektiven oder nicht reproduzierbaren Bildanalyse abschwächen können. Diese Arbeit etabliert Richtlinien dafür, wie DL verwendet werden kann, um die generelle Qualität der Analyse biologischer Bilddaten zu erhöhen. KW - Deeplearning KW - Biologie KW - Bildanalyse KW - bioimage analysis Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-243728 ER - TY - THES A1 - Schweizer, Ulrich T1 - Genetische Untersuchungen zur Rolle von Cytochrom C und Stat3 bei der Regulation des embryonalen Zelltods von Motoneuronen der Maus T1 - Genetic studies on the role of Cytochrome C and Stat3 for the regulation of the cell death of embryonic mouse motoneurons N2 - Genetische Inaktivierung des somatischen Cytochrom C Gens der Maus Cytochrom C wurde als ein Interaktionspartner im Apoptosom beschrieben. Ziel dieses Projektes war es, die Rolle von Cytochrom C bei der Apoptose von Nervenzellen in vivo durch genetische Inaktivierung in der Maus zu untersuchen. Die homozygote Deletion des Cytochrom C Gens führt jedoch zu einem sehr frühen Entwicklungsdefekt: Schon am 8. Embryonaltag findet man nur noch Embryonen ohne erkennbare Körperachse. Im weiteren wurden daher heterozygote Tiere untersucht, die in bestimmten Geweben, wie Gehirn und Rückenmark, eine Reduktion der Menge von Cytochrom C aufweisen. Am ersten Tag nach der Geburt konnten keine Unterschiede zwischen Tieren mit einem oder zwei Cytochrom C Genen in Bezug die Anzahl von Motoneuronen gefunden werden. Auch nach perinataler Fazialisläsion war die Rate des Zelltods bei Tieren mit heterozygoter Deletion des Cytochrom C Gens unverändert. In vitro zeigte sich jedoch eine erhöhte Resitenz von Motoneuronen gegenüber Fas-induzierter Apoptose. Bei der Analyse der Apoptose von Thymozyten zeigte sich ein Trend, der eine kleine, aber reproduzierbare Verzögerung einer späten Zelltodphase nach UV-induzierter Apoptose nahelegt. Erste Experimente deuten außerdem auf einen Effekt der Cytochrom C Gendosis auf den Verlauf einer Experimentellen Autoimmunencephalitis (EAE) hin. Charakterisierung der NFL-Cre Maus Die zelltypspezifische Genablation mit dem Cre/loxP System umgeht einige der größten Probleme der klassischen Methode der Geninaktivierung in Mäusen, indem nur in bestimmten Geweben oder Zelltypen, eventuell sogar nur ab einem bestimmten Zeitpunkt, ein Gen gezielt ausgeschaltet werden kann. Allerdings hängt das Cre/loxP System von der Verfügbarkeit von brauchbaren Cre-transgenen Mauslinien mit entsprechenden Expressionsmustern und –kinetiken ab. Wir haben eine transgene Mauslinie etabliert und analysiert, die die Cre Rekombinase unter der Kontrolle des humanen Neurofilament-L Promotors exprimiert. Das Expressionsmuster von Cre wurde in mehreren Geweben mit RT-PCR und durch Verkreuzung mit einer Reportergenmaus untersucht. Im Gehirn wurden Cre exprimierende Zelltypen mit in-situ Hybridisierung, Immunhistochemie und wiederum mit Hilfe der Reportermaus identifiziert. Dabei zeigte sich eine spezifische Cre Expression in bestimmten Neuronpopulationen wie hippocampalen Pyramidenzellen und spinalen und cranialen Motoneuronen. Unsere NFL-Cre Maus besitzt einige Eigenschaften, die bisher publizierte Cre-Linien nicht aufweisen, so z.B.eine starke Cre Expression in hippocampalen Pyramidenzellen, aber nicht in Körnerzellen des Gyrus dentatus; Expression in cortikalen Pyramidenzellen, aber keine Expression im Striatum; Expression in zerebellären Purkinje-, aber nicht Körnerzellen; sowie die Expression in spinalen und cranialen Motoneuronen, aber nicht in angrenzenden Interneuronen. Die Rolle von Stat3 für das Überleben von Motoneuronen Die Mitglieder der CNTF/LIF/Cardiotrophin Genfamilie sind potente Überlebensfaktoren für embryonale und lädierte Motoneurone sowohl in vitro als auch in vivo. Diese Faktoren binden an Rezeptorkomplexe, die gp130 und LIFR als signaltransduzierende Komponenten enthalten. Im Gegensatz zu den Rezeptoren für andere neurotrophe Faktoren, führt die Aktivierung von gp130 und LIFR zur Phosphorylierung und Aktivierung des Transkriptionsfaktors Stat3. Es war aber zu Beginn dieser Arbeiten unklar, ob die Aktivierung von Stat3 für den Überlebenseffekt der neuropoietischen Zytokine notwendig ist. Um diese Frage zu beantworten, wurde Stat3 in Motoneuronen mit Hilfe des Cre/loxP Systems konditional inaktiviert. Stat3 ist nicht für das Überleben embryonaler Motoneurone essentiell, obwohl man in vitro eine Verschiebung der Dosis-Wirkungskurve für CNTF findet. In vivo hingegen kann kein erhöhter Zelltod von Motoneuronen nachgewiesen werden. Im Gegensatz dazu, kommt es bei adulten Tieren mit Inaktivierung von Stat3 in Motoneuronen zu einem erhöhten Zelltod nach Fazialisläsion. Diese Neurone können wiederum durch die Applikation neurotropher Faktoren, einschließlich CNTF, gerettet werden. Durch semiquantitative RT-PCR kann man zeigen, daß Stat3-regulierte Gene, deren Expression nach Nervenläsion induziert wird, in Neuronen mit Inaktivierung von Stat3 weniger stark exprimiert werden. Zu diesen Genen gehören Reg-2, ein Mitogen für Schwannzellen, das von regenerierenden Neuronen exprimiert wird, und Bcl-xL, ein Gen, welches direkt in die Apoptoseregulation eingreift. Diese Daten zeigen, daß Stat3 Aktivierung eine essentielle Rolle für das Überleben nach Läsion von postnatalen Motoneuronen spielt, aber nicht während der Embryonalentwicklung. Das bedeutet, daß die Signalwege ein und desselben neurotrophen Faktors sich während der Entwicklung und reifung des Organismus verändern können. N2 - Genetic inactivation of the somatic cytochrome C gene in mice Cytochrome C has been described as a component of the apoptosome. It was the aim of this project to analyze the role of cytochrome C in apoptosis of neurons in vivo by genetic inactivation in mice. Mice lacking cytochrome C, however, exhibit a very early embryonic phenotype: On embryonic day 8, only highly degenerated embryos can be found which even lack a body axis. Therefore, we subsequently analyzed heterozygous animals, as they showed a gene dose-dependent reduction of cytochrome C protein in several tissues, including brain and spinal cord. Testing motoneuron survival after development or after facial nerve lesion, we found no significant differences between heterozygous animals and their wildtype litter mates. In vitro, however, an increased resistance toward Fas-mediated apoptosis was observed in heterozygous motoneurons. When we analyzed induced apoptosis of thymozytes, we consistently found that a late phase of cell death was delayed in cytochrome C heterozygous cells. Characterization of the Cre-transgenic NFL-Cre mouse Cell type-specific gene ablation using the Cre/loxP technology can circumvent some of the greatest problems encountered with classical gene inactivation by selective inactivation of the gene of interest in a particular tissue or cell type, possibly at a specific time point. However, the Cre/loxP technology critically depends on the availability of suitable Cre-transgenic mouse lines. We have established and characterized a transgenic mouse line that expresses Cre recombinase under control of the human neurofilament-L promoter. Cre expression was studied by RT-PCR and cross-breeding with lacZ reporter mice. Our NFL-Cre mice exhibit some unique features not shared with other available Cre transgenic mouse lines: We find high Cre expression in hippocampal pyramidal neurons while granule cells in the dentate gyrus do not express Cre. In addition, we observed widespread Cre expression in cortical neurons, but none in striatal neurons. Finally, Cre is expressed in cranial and spinal motoneurons, but not in adjacent interneurons. The role of Stat3 for the survival of motoneurons Members of the CNTF/LIF/Cardiotrophin gene family are potent survival factors for embryonic and lesioned motoneurons in vitro as well as in vivo. These factors act through receptor comlexes containing gp130 and LIFR signal transducing subunits. A particular feature of these receptors is that their activation leads to phosphorylation and activation of the transcription factor Stat3, while neurotrophin receptors do not activate Stat3. It was the aim of this project to find out whether Stat3 activation in response to CNTF binding is required for its survival effect on motoneurons. Therefore, we conditionally inactivated Stat3 in motoneurons using our NFL-Cre transgenic mice. In NFL-Cre; Stat3flox/KO mice, we find that Stat3 is not essential for motoneuron survival during the the period of naturally occurring cell death, although motoneurons from these mice require higher doses of CNTF for their survival in vitro. In contrast, motoneuron survival is significantly reduced after facial nerve lesion in adult NFL-Cre; Stat3flox/KO mice. Stat3 proved essential for upregulation of Reg-2 and Bcl-xL expression in lesioned motoneurons. These data show that Stat3 activation plays an important role for motoneuron survival after nerve lesion in postnatal life but not during embryonic development, indicating that signaling requirements for motoneuron survival change during maturation. KW - Cytochrom c KW - Apoptosis KW - Nervenzelle KW - Cytochrom C KW - Stat3 KW - Motoneuron KW - Fazialisläsion KW - LIFR KW - Cytochrome C KW - Stat3 KW - motoneuron KW - facial nerve lesion KW - LIFR Y1 - 2002 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-3732 ER - TY - THES A1 - Schulte, Annemarie T1 - \(In\) \(vitro\) reprogramming of glial cells from adult dorsal root ganglia into nociceptor-like neurons T1 - \(In\) \(vitro\) Reprogrammierung von Gliazellen aus adulten Spinalganglien in Nozizeptor-ähnliche Neurone N2 - Plexus injury often occurs after motor vehicle accidents and results in lifelong disability with severe neuropathic pain. Surgical treatment can partially restore motor functions, but sensory loss and neuropathic pain persist. Regenerative medicine concepts, such as cell replacement therapies for restoring dorsal root ganglia (DRG) function, set high expectations. However, up to now, it is unclear which DRG cell types are affected by nerve injury and can be targeted in regenerative medicine approaches. This study followed the hypothesis that satellite glial cells (SGCs) might be a suitable endogenous cell source for regenerative medicine concepts in the DRG. SGCs originate from the same neural crest-derived cell lineage as sensory neurons, making them attractive for neural repair strategies in the peripheral nervous system. Our hypothesis was investigated on three levels of experimentation. First, we asked whether adult SGCs have the potential of sensory neuron precursors and can be reprogrammed into sensory neurons in vitro. We found that adult mouse DRG harbor SGC-like cells that can still dedifferentiate into progenitor-like cells. Surprisingly, expression of the early developmental transcription factors Neurog1 and Neurog2 was sufficient to induce neuronal and glial cell phenotypes. In the presence of nerve growth factor, induced neurons developed a nociceptor-like phenotype expressing functional nociceptor markers, such as the ion channels TrpA1, TrpV1 and NaV1.9. In a second set of experiments, we used a rat model for peripheral nerve injury to look for changes in the DRG cell composition. Using an unbiased deep learning-based approach for cell analysis, we found that cellular plasticity responses after nerve injury activate SGCs in the whole DRG. However, neither injury-induced neuronal death nor gliosis was observed. Finally, we asked whether a severe nerve injury changed the cell composition in the human DRG. For this, a cohort of 13 patients with brachial plexus injury was investigated. Surprisingly, in about half of all patients, the injury-affected DRG showed no characteristic DRG tissue. The complete entity of neurons, satellite cells, and axons was lost and fully replaced by mesodermal/connective tissue. In the other half of the patients, the basic cellular entity of the DRG was well preserved. Objective deep learning-based analysis of large-scale bioimages of the “intact” DRG showed no loss of neurons and no signs of gliosis. This study suggests that concepts for regenerative medicine for restoring DRG function need at least two translational research directions: reafferentation of existing DRG units or full replacement of the entire multicellular DRG structure. For DRG replacement, SGCs of the adult DRG are an attractive endogenous cell source, as the multicellular DRG units could possibly be rebuilt by transdifferentiating neural crest-derived sensory progenitor cells into peripheral sensory neurons and glial cells using Neurog1 and Neurog2. N2 - Plexusläsionen treten häufig nach Verkehrsunfällen auf und führen zu lebenslangen Einschränkungen mit starken neuropathischen Schmerzen. Eine operative Behandlung kann die motorischen Funktionen teilweise wiederherstellen, dennoch bleiben Verlust der Sensorik und neuropathische Schmerzen bestehen. Ansätze der regenerativen Medizin, wie z. B. Zellersatztherapien zur Wiederherstellung der Funktion der Spinalganglien, wecken hohe Erwartungen. Bislang ist jedoch vollkommen unklar, welche Zelltypen der Spinalganglien von der Nervenverletzung betroffen sind und bei Ansätzen der regenerativen Medizin gezielt eingesetzt werden sollten. Hier war die Hypothese, dass Satellitengliazellen (SGCs) eine geeignete endogene Zellquelle für Ansätze der regenerativen Medizin in den Spinalganglien sein könnten. SGCs und sensorische Neurone stammen von denselben Stammzellen der Neuralleiste ab, was SGCs für neurale Reparaturstrategien im peripheren Nervensystem attraktiv macht. Unsere Hypothese wurde auf drei Ebenen experimentell untersucht. Zuerst stellten wir die Frage, ob adulte SGCs das Potenzial haben, neuronale Vorläufermerkmale anzunehmen und in vitro in sensorische Neuronen reprogrammiert werden können. Hierbei zeigte sich, dass Spinalganglien der Maus adulte SGC-ähnliche Zellen beherbergen, die sich in vorläuferähnliche Zellen dedifferenzieren können. Überraschenderweise war die Expression der frühen entwicklungsrelevanten Transkriptions-faktoren Neurog1 und Neurog2 ausreichend, um neuronale und gliale Phänotypen zu induzieren. In Anwesenheit des Neurotrophins NGF (nerve growth factor) entwickelten die induzierten Neurone einen Nozizeptor-ähnlichen Phänotyp, der funktionelle Marker für Nozizeptoren wie die Ionenkanäle TrpA1, TrpV1 und NaV1.9 exprimierte. In einer zweiten Reihe von Experimenten haben wir in einem Rattenmodell für periphere Nervenverletzungen Veränderungen in der Zellzusammensetzung von Spinalganglien untersucht. Mithilfe eines objektiven Deep Learning basierten Ansatzes zur Bildanalyse fanden wir im gesamten DRG SGCs, die auf Nervenverletzungen mit einer hohen zellulären Plastizität reagierten. Es wurde jedoch weder ein verletzungsbedingter neuronaler Verlust noch eine Gliose beobachtet. Schließlich untersuchten wir, ob eine schwere Nervenverletzung die Zellzusammensetzung in menschlichen Spinalganglien verändert. Dazu wurde eine Kohorte von 13 Patienten mit einer Verletzung des Plexus brachialis untersucht. Überraschenderweise zeigte sich in verletzten Spinalganglien bei etwa der Hälfte aller Patienten kein Spinalgangliengewebe mehr. Die gesamte Einheit aus Neuronen, Satellitengliazellen und Axonen war verloren und vollständig durch mesodermales Bindegewebe ersetzt. Bei der anderen Hälfte der Patienten war die grundlegende zelluläre Einheit des Spinalganglions gut erhalten. Eine objektive, auf Deep Learning basierende Analyse von großflächigen Mikroskopiebildern des "intakten" Spinalganglions zeigte keinen Verlust von Neuronen und keine Anzeichen von Gliose. Diese Studie legt nahe, dass zur Wiederherstellung der Funktionen des Spinalganglions mindestens zwei translationale Forschungsrichtungen der regenerativen Medizin erforderlich sind: Reafferenzierung bestehender Spinalganglion-Einheiten oder vollständiger Ersatz der gesamten multizellulären Spinalganglion-Struktur. Für den Ersatz des Spinalganglions sind SGCs des adulten Spinalganglions eine plausible endogene Zellquelle. Die multizellulären Einheiten des Spinalganglions könnten möglicherweise durch eine Neurog1- und Neurog2- induzierte Transdifferenzierung von sensorischen Vorläuferzellen der Neuralleiste in periphere sensorische Neuronen und Gliazellen wiederaufgebaut werden. KW - Spinalganglion KW - Reprogrammming KW - Satellite glial cell KW - Nociceptor KW - Dorsal root ganglion Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-303110 ER - TY - THES A1 - Schukraft [geb. Scheffler], Nina T1 - Integrated defensive states and their neuronal correlates in the Periaqueductal Gray T1 - Integrierte Defensivzustände und ihre neuronalen Korrelate im Periaquäduktalen Grau N2 - In the face of threat, animals react with a defensive reaction to avoid or reduce harm. This defensive reaction encompasses apart from behavioral changes also physiological, analgetic, and endocrine adaptations. Nonetheless, most animal studies on fear and anxiety are based on behavioral observations only, disregarding other aspects of the defensive reaction, or integrating their inter-related dynamics only insufficiently. The first part of this thesis aimed in characterizing patterned associations of behavioral and physiological responses, termed integrated defensive states. Analyzing cardiac and behavioral responses in mice undergoing multiple fear and anxiety paradigms revealed a complex and dynamic interaction of those readouts on both, short and long timescales. Microstates, stereotypical combinations of i.e. freezing and decelerating heart rates, are short-lasting and were, in turn, shown to be influenced by slow acting macrostate changes. One of those higher order macrostates, called `rigidity`, was defined as a latent process that constrains the range of momentary displayed heart rate values. Furthermore, integrated defensive states were found to be highly dependent on the cue and the context the animals are confronted with. Importantly, same behavioral observations, i.e. freezing, were associated with distinct cardiac responses, highlighting the importance of multivariate analysis of integrated defensive states. Defensive states are orchestrated by the brain, which has evolved evolutionary conserved survival circuits. A central brain area of these circuits is the periaqueductal gray (PAG) in the midbrain. It plays a pivotal role in mediating defensive states, as it receives signals about external and internal information from multiple brain regions and sends information to both, higher order brain areas as well as to the brainstem ultimately causing the execution of threat responses. In the second part of this thesis, different neuronal circuit elements in the PAG were optically manipulated in order to gain mechanistic insight into the defense network in the brain underlying the previously delineated cardio-behavioral defensive states. Optical activation of glutamatergic PAG neurons evoked heterogeneous, light-intensity dependent responses. However, a further molecular restriction of the glutamatergic neuronal population targeting only Chx10+ neurons, led to a cardio-behavioral state that resembled spontaneous freezing-bradycardia bouts. In summary, this thesis presents a multivariate description of defensive states, which includes the complex interaction of cardiac and behavioral responses on different timescales and, furthermore, functionally dissects different excitatory and inhibitory PAG circuit elements mediating these defensive states. N2 - Tiere reagieren mit einer Abwehrreaktion auf eine Bedrohung, um Schaden zu vermeiden oder zu verringern. Diese Abwehrreaktion umfasst neben Verhaltensänderungen auch physiologische, analgetische und endokrine Anpassungen. Dennoch stützen sich die meisten Tierstudien auf dem Gebiet von Furcht- und Angstforschung nur auf Verhaltensbeobachtungen und lassen dabei andere Aspekte der Abwehrreaktion außer Acht oder berücksichtigen ihre komplexen gegenseitigen Beziehungen nur unzureichend. Das Ziel des ersten Teils dieser Arbeit war, bestimmte Zusammenhänge von Verhalten und physiologischen Reaktionen zu charakterisieren, die hier als integrierte Defensivzustände bezeichnet werden. Um Defensivzustände bei Mäusen hervorzurufen, wurden diese mehreren Furcht- und Angstparadigmen unterzogen. Die Analyse der dabei hervorgerufenen Herzratenänderungen und Verhaltensanpassungen ergab eine komplexe und dynamische Interaktion dieser beiden Reaktionen, bei denen sowohl kurz- als auch auf längerfristige Änderungen eine Rolle spielen. Mikrozustände, stereotype Kombinationen von z. B. Freezing und Verlangsamung der Herzfrequenz, sind von kurzer Dauer und werden wiederum durch langsamer wirkende Makrozustände beeinflusst. Einer dieser auf einer übergeordneteren Ebene wirkenden Makrozustände, "rigidity" genannt, wurde als latenter Prozess definiert, der den Ausprägungsbereich der zu jedem Zeitpunkt möglichen Maximal- und Minimalherzfrequenz beschreibt. Darüber hinaus wurde festgestellt, dass integrierte Defensivzustände in hohem Maße von dem Auslösereiz und dem Kontext abhängen, mit dem die Tiere konfrontiert werden. Eine wichtige Erkenntnis hierbei war, dass dieselben Verhaltensbeobachtungen, z. B. Freezing, mit unterschiedlichen kardialen Antworten assoziiert sein kann. Dies unterstreicht die Bedeutsamkeit von multivariaten Analysen integrierter Defensivzustände. Defensivzustände werden vom Gehirn gesteuert, das evolutionär konservierte neuronale Überlebensschaltkreise entwickelt hat. Ein zentrales Hirnareal dieser Schaltkreise ist das Periaquäduktale Grau (PAG) im Mittelhirn. Diese Hirnstruktur spielt eine wichtige Rolle bei der Vermittlung von Defensivzuständen, da es diverse Signale über sowohl äußere als auch innere Zustände aus multiplen Hirnregionen empfängt und gleichzeitig Informationen an Hirnareale höherer Ordnung sowie an den Hirnstamm sendet, der letztendlich die Ausführung von Defensivreaktionen vermittelt. Im zweiten Teil dieser Arbeit wurden verschiedene neuronale Schaltkreiselemente im PAG optogenetisch manipuliert, um einen mechanistischen Einblick in das Defensivnetzwerk im Gehirn zu erhalten, das den zuvor beschriebenen kardio-verhaltensmäßigen Defensivzuständen zugrunde liegt. Die optische Aktivierung von glutamatergen PAG-Neuronen war mit einer heterogenen, von der Lichtintensität abhängigen Reaktionen assoziiert. Eine weitere molekulare Restriktion der glutamatergen Neuronenpopulation, die nun ausschließlich auf Chx10+ Neuronen abzielte, führte hingegen zu einem kardio-verhaltensmäßigen Zustand, der vergleichbar mit zuvor beobachteten spontanen Freezing-Bradykardie-Zuständen war. Zusammenfassend umfasst diese Arbeit eine multivariate Beschreibung von Defensivzuständen, die das komplexe Zusammenspiel von kardialen und verhaltensmäßigen Reaktionen auf verschiedenen Zeitachsen umfasst sowie - mittels Optogenetik - eine funktionelle Charakterisierung von verschiedenen exzitatorischen und inhibitorischen PAG-Schaltkreiselementen, die diese Defensivzustände vermitteln. KW - Perianova, Irina KW - Integrated Defensive States KW - Periaqueductal gray Y1 - 2024 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-347458 ER - TY - JOUR A1 - Schuhmann, Michael K. A1 - Papp, Lena A1 - Stoll, Guido A1 - Blum, Robert A1 - Volkmann, Jens A1 - Fluri, Felix T1 - Mesencephalic electrical stimulation reduces neuroinflammation after photothrombotic stroke in rats by targeting the cholinergic anti-inflammatory pathway JF - International Journal of Molecular Sciences N2 - Inflammation is crucial in the pathophysiology of stroke and thus a promising therapeutic target. High-frequency stimulation (HFS) of the mesencephalic locomotor region (MLR) reduces perilesional inflammation after photothrombotic stroke (PTS). However, the underlying mechanism is not completely understood. Since distinct neural and immune cells respond to electrical stimulation by releasing acetylcholine, we hypothesize that HFS might trigger the cholinergic anti-inflammatory pathway via activation of the α7 nicotinic acetylcholine receptor (α7nAchR). To test this hypothesis, rats underwent PTS and implantation of a microelectrode into the MLR. Three hours after intervention, either HFS or sham-stimulation of the MLR was applied for 24 h. IFN-γ, TNF-α, and IL-1α were quantified by cytometric bead array. Choline acetyltransferase (ChAT)\(^+\) CD4\(^+\)-cells and α7nAchR\(^+\)-cells were quantified visually using immunohistochemistry. Phosphorylation of NFĸB, ERK1/2, Akt, and Stat3 was determined by Western blot analyses. IFN-γ, TNF-α, and IL-1α were decreased in the perilesional area of stimulated rats compared to controls. The number of ChAT\(^+\) CD4\(^+\)-cells increased after MLR-HFS, whereas the amount of α7nAchR\(^+\)-cells was similar in both groups. Phospho-ERK1/2 was reduced significantly in stimulated rats. The present study suggests that MLR-HFS may trigger anti-inflammatory processes within the perilesional area by modulating the cholinergic system, probably via activation of the α7nAchR. KW - photothrombotic stroke KW - deep brain stimulation KW - mesencephalic locomotor region KW - neuroinflammation KW - choline acetyltransferase KW - alpha-7 nicotinic acetylcholine receptor Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259099 SN - 1422-0067 VL - 22 IS - 3 ER - TY - JOUR A1 - Schmitt, Dominique A1 - Funk, Natalia A1 - Blum, Robert A1 - Asan, Esther A1 - Andersen, Lill A1 - Rülicke, Thomas A1 - Sendtner, Michael A1 - Buchner, Erich T1 - Initial characterization of a Syap1 knock-out mouse and distribution of Syap1 in mouse brain and cultured motoneurons JF - Histochemistry and Cell Biology N2 - Synapse-associated protein 1 (Syap1/BSTA) is the mammalian homologue of Sap47 (synapse-associated protein of 47 kDa) in Drosophila. Sap47 null mutant larvae show reduced short-term synaptic plasticity and a defect in associative behavioral plasticity. In cultured adipocytes, Syap1 functions as part of a complex that phosphorylates protein kinase B alpha/Akt1 (Akt1) at Ser\(^{473}\) and promotes differentiation. The role of Syap1 in the vertebrate nervous system is unknown. Here, we generated a Syap1 knock-out mouse and show that lack of Syap1 is compatible with viability and fertility. Adult knock-out mice show no overt defects in brain morphology. In wild-type brain, Syap1 is found widely distributed in synaptic neuropil, notably in regions rich in glutamatergic synapses, but also in perinuclear structures associated with the Golgi apparatus of specific groups of neuronal cell bodies. In cultured motoneurons, Syap1 is located in axons and growth cones and is enriched in a perinuclear region partially overlapping with Golgi markers. We studied in detail the influence of Syap1 knockdown and knockout on structure and development of these cells. Importantly, Syap1 knockout does not affect motoneuron survival or axon growth. Unexpectedly, neither knockdown nor knockout of Syap1 in cultured motoneurons is associated with reduced Ser\(^{473}\) or Thr\(^{308}\) phosphorylation of Akt. Our findings demonstrate a widespread expression of Syap1 in the mouse central nervous system with regionally specific distribution patterns as illustrated in particular for olfactory bulb, hippocampus, and cerebellum. KW - Protein kinase B KW - Spinal Muscular-arthropy KW - Rictor-mTOR complex KW - Neurotrophic factors KW - Plasma-membrane KW - Axon growth KW - SAP47 gene KW - Phosphorylation KW - Drosophilia KW - Cells KW - BSTA KW - Viability KW - Brain KW - Syap1 localization KW - Glutamatergic synapses KW - PKB/Akt phosphorylation Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-187258 VL - 146 IS - 4 ER - TY - THES A1 - Schmitt, Dominique T1 - Initial characterization of mouse Syap1 in the nervous system: Search for interaction partners, effects of gene knockdown and knockout, and tissue distribution with focus on the adult brain T1 - Erste Charakterisierung des Maus-Syap1 im Nervensystem: Suche nach Interaktionspartnern, Auswirkungen von Gen-Knockdown und-Knockout sowie Untersuchungen über die Verteilung im Gewebe mit Fokus auf das adulte Gehirn N2 - The synapse-associated protein of 47 kDa (Sap47) in Drosophila melanogaster is the founding member of a phylogenetically conserved protein family of hitherto unknown molecular function. Sap47 is localized throughout the entire neuropil of adult and larval brains and closely associated with glutamatergic presynaptic vesicles of larval motoneurons. Flies lacking the protein are viable and fertile and do not exhibit gross structural or marked behavioral deficiencies indicating that Sap47 is dispensable for basic synaptic function, or that its function is compensated by other related proteins. Syap1 - the mammalian homologue of Sap47 - was reported to play an essential role in Akt1 phosphorylation in various non-neuronal cells by promoting the association of mTORC2 with Akt1 which is critical for the downstream signaling cascade for adipogenesis. The function of Syap1 in the vertebrate nervous system, however, is unknown so far. The present study provides a first description of the subcellular localization of mouse Syap1 in cultured motoneurons as well as in selected structures of the adult mouse nervous system and reports initial functional experiments. Preceding all descriptive experiments, commercially available Syap1 antibodies were tested for their specificity and suitability for this study. One antibody raised against the human protein was found to recognize specifically both the human and murine Syap1 protein, providing an indispensable tool for biochemical, immunocytochemical and immunohistochemical studies. In the course of this work, a Syap1 knockout mouse was established and investigated. These mice are viable and fertile and do not show obvious changes in morphology or phenotype. As observed for Sap47 in flies, Syap1 is widely distributed in the synaptic neuropil, particularly in regions rich in glutamatergic synapses but it was also detected at perinuclear Golgi-associated sites in certain groups of neuronal somata. In motoneurons the protein is especially observed in similar perinuclear structures, partially overlapping with Golgi markers and in axons, dendrites and axonal growth cones. Biochemical and immunohistochemical analyses showed widespread Syap1 expression in the central nervous system with regionally distinct distribution patterns in cerebellum, hippocampus or olfactory bulb. Besides its expression in neurons, Syap1 is also detected in non-neuronal tissue e.g. liver, kidney and muscle tissue. In contrast, non-neuronal cells in the brain lack the typical perinuclear accumulation. First functional studies with cultured primary motoneurons on developmental, structural and functional aspects reveal no influence of Syap1 depletion on survival and morphological features such as axon length or dendritic length. Contrary to expectations, in neuronal tissues or cultured motoneurons a reduction of Akt phosphorylation at Ser473 or Thr308 was not detected after Syap1 knockdown or knockout. N2 - Das Synapsen-assoziierte Protein von 47 kDa (Sap47) in Drosophila melanogaster ist das Gründungsmitglied einer phylogenetisch konservierten Proteinfamilie von unbekannter molekularer Funktion. Sap47 ist im gesamten Neuropil des adulten und larvalen Gehirns lokalisiert und mit glutamatergen, präsynaptischen Vesikeln in larvalen Motoneuronen assoziiert. Fliegen, denen das Protein fehlt, sind lebensfähig und fruchtbar und weisen keine schwerwiegenden strukturellen oder ausgeprägten verhaltensbezogenen Defizite auf, was darauf hinweist, dass Sap47 für eine basale synaptische Funktion entbehrlich ist beziehungsweise das Fehlen seiner Funktion durch andere, eventuell verwandte Proteine, kompensiert werden kann. Über Syap1 - das Säugetierhomolog von Sap47 - wurde berichtet, dass es in verschiedenen nicht-neuronalen Zellen eine essentielle Rolle in der Akt1 Phosphorylierung spielt, indem es die Assoziation von mTORC2 und Akt1 begünstigt, welche für den nachgeschalteten Signalweg bei der Adipogenese essentiell ist. Die Funktion von Syap1 im Vertebraten-Nervensystem ist dagegen bislang unbekannt. Die vorliegende Studie liefert die Erstbeschreibung von neuronalem Syap1 über die subzelluläre Lokalisation des Proteins in kultivierten Motoneuronen sowie die Verteilung in ausgewählten Strukturen des adulten Nervensystems der Maus und beschreibt initiale funktionelle Experimente. Allen beschreibenden Experimenten voran, wurden kommerziell erhältliche Syap1 Antikörper auf ihre Spezifität und Tauglichkeit für diese Studie getestet. Einer der Antikörper, der gegen das humane Protein hergestellt wurde, erkennt spezifisch sowohl das humane, als auch das murine Syap1 Protein und stellt somit ein unentbehrliches Werkzeug für alle biochemischen, immunzytochemischen und immunhistochemischen Untersuchungen dar. Im Zuge der Arbeit wurde eine Syap1-Knockout Maus untersucht, welche vital und fruchtbar ist und keine offensichtlichen Veränderungen in ihrem morphologischen Phänotyp aufweist. Wie auch Sap47 in Fliegen, ist Syap1 im synaptischen Neuropil weit verbreitet, insbesondere in Regionen, die reich an glutamatergen Synapsen sind, aber es wurde auch in einer deutlichen, Golgi-assoziierten Akkumulation in bestimmten Gruppen neuronaler Zellkörper beobachtet. In Motoneuronen wurde das Protein besonders in ähnlichen perinukleären Strukturen detektiert, welche zum Teil mit Golgi Markern überlappen und zudem in Axonen, Dendriten und Wachstumskegeln detektiert. Wie biochemische und immunhistochemische Untersuchungen ergaben, zeigt das Syap1 Protein eine weit verbreitete Expression im zentralen Nervensystem mit Regionen-spezifischem Verteilungsmuster wie es beispielsweise im Kleinhirn, dem Hippocampus oder dem olfaktorischen Bulbus beobachtet wurde. Neben der Expression in Neuronen wurde Syap1 auch in nicht neuronalen Geweben wie der Leber, Niere und im Muskel detektiert. Nicht-neuronalen Zellen im Gehirn fehlte dagegen die typische perinukleäre Akkumulation in immunhistochemischen Färbungen. Erste funktionelle Studien mit kultivierten primären Motoneuronen über entwicklungsbezogene, strukturelle und funktionelle Gesichtspunkte ergaben keinen Einfluss einer Syap1 Depletion auf das Überleben oder morphologische Merkmale wie Axon- oder Dendritenlänge. Entgegen den Erwartungen, wurde nach Syap1 Knockdown oder Knockout in neuronalem Gewebe oder kultivierten Motoneuronen keine Reduktion in der Akt1 Phosphorylierung an Ser473 oder Thr308 detektiert. KW - Synapse KW - Nervensystem KW - Motoneuron KW - Golgi-Apparat KW - Syap1 KW - Sap47 KW - Synapse-associated protein KW - Golgi apparatus KW - Synapsen assoziiert Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-147319 ER - TY - JOUR A1 - Schaefer, Natscha A1 - Vogel, Nicolas A1 - Villmann, Carmen T1 - Glycine receptor mutants of the mouse: what are possible routes of inhibitory compensation? JF - Frontiers in Molecular Neuroscience N2 - Defects in glycinergic inhibition result in a complex neuromotor disorder in humans known as hyperekplexia (OMIM 149400) with similar phenotypes in rodents characterized by an exaggerated startle reflex and hypertonia. Analogous to genetic defects in humans single point mutations, microdeletions, or insertions in the Glra1 gene but also in the Glrb gene underlie the pathology in mice. The mutations either localized in the (spasmodic, oscillator, cincinnati, Nmf11) or the (spastic) subunit of the glycine receptor (GlyR) are much less tolerated in mice than in humans, leaving the question for the existence of different regulatory elements of the pathomechanisms in humans and rodents. In addition to the spontaneous mutations, new insights into understanding of the regulatory pathways in hyperekplexia or glycine encephalopathy arose from the constantly increasing number of knock-out as well as knock-in mutants of GlyRs. Over the last five years, various efforts using in vivo whole cell recordings provided a detailed analysis of the kinetic parameters underlying glycinergic dysfunction. Presynaptic compensation as well as postsynaptic compensatory mechanisms in these mice by other GlyR subunits or GABA(A) receptors, and the role of extra-synaptic GlyRs is still a matter of debate. A recent study on the mouse mutant oscillator displayed a novel aspect for compensation of functionality by complementation of receptor domains that fold independently. This review focuses on defects in glycinergic neurotransmission in mice discussed with the background of human hyperekplexia en route to strategies of compensation. KW - GlyRs KW - rescue KW - hyperekplexia KW - knockout mice KW - spontaneous mouse mutants KW - synaptic inhibition Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-123839 VL - 5 IS - 98 ER - TY - JOUR A1 - Schaefer, Natascha A1 - Zheng, Fang A1 - van Brederode, Johannes A1 - Berger, Alexandra A1 - Leacock, Sophie A1 - Hirata, Hiromi A1 - Paige, Christopher J. A1 - Harvey, Robert J. A1 - Alzheimer, Christian A1 - Villmann, Carmen T1 - Functional Consequences of the Postnatal Switch From Neonatal to Mutant Adult Glycine Receptor α1 Subunits in the Shaky Mouse Model of Startle Disease JF - Frontiers in Molecular Neuroscience N2 - Mutations in GlyR α1 or β subunit genes in humans and rodents lead to severe startle disease characterized by rigidity, massive stiffness and excessive startle responses upon unexpected tactile or acoustic stimuli. The recently characterized startle disease mouse mutant shaky carries a missense mutation (Q177K) in the β8-β9 loop within the large extracellular N-terminal domain of the GlyR α1 subunit. This results in a disrupted hydrogen bond network around K177 and faster GlyR decay times. Symptoms in mice start at postnatal day 14 and increase until premature death of homozygous shaky mice around 4–6 weeks after birth. Here we investigate the in vivo functional effects of the Q177K mutation using behavioral analysis coupled to protein biochemistry and functional assays. Western blot analysis revealed GlyR α1 subunit expression in wild-type and shaky animals around postnatal day 7, a week before symptoms in mutant mice become obvious. Before 2 weeks of age, homozygous shaky mice appeared healthy and showed no changes in body weight. However, analysis of gait and hind-limb clasping revealed that motor coordination was already impaired. Motor coordination and the activity pattern at P28 improved significantly upon diazepam treatment, a pharmacotherapy used in human startle disease. To investigate whether functional deficits in glycinergic neurotransmission are present prior to phenotypic onset, we performed whole-cell recordings from hypoglossal motoneurons (HMs) in brain stem slices from wild-type and shaky mice at different postnatal stages. Shaky homozygotes showed a decline in mIPSC amplitude and frequency at P9-P13, progressing to significant reductions in mIPSC amplitude and decay time at P18-24 compared to wild-type littermates. Extrasynaptic GlyRs recorded by bath-application of glycine also revealed reduced current amplitudes in shaky mice compared to wild-type neurons, suggesting that presynaptic GlyR function is also impaired. Thus, a distinct, but behaviorally ineffective impairment of glycinergic synapses precedes the symptoms onset in shaky mice. These findings extend our current knowledge on startle disease in the shaky mouse model in that they demonstrate how the progression of GlyR dysfunction causes, with a delay of about 1 week, the appearance of disease symptoms. KW - glycine receptor KW - startle disease KW - β8-β9 loop KW - mouse model KW - fast decay Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-196056 SN - 1662-5099 VL - 11 IS - 167 ER - TY - JOUR A1 - Schaefer, Natascha A1 - Signoret-Genest, Jérémy A1 - von Collenberg, Cora R. A1 - Wachter, Britta A1 - Deckert, Jürgen A1 - Tovote, Philip A1 - Blum, Robert A1 - Villmann, Carmen T1 - Anxiety and Startle Phenotypes in Glrb Spastic and Glra1 Spasmodic Mouse Mutants JF - Frontiers in Molecular Neuroscience N2 - A GWAS study recently demonstrated single nucleotide polymorphisms (SNPs) in the human GLRB gene of individuals with a prevalence for agoraphobia. GLRB encodes the glycine receptor (GlyRs) β subunit. The identified SNPs are localized within the gene flanking regions (3′ and 5′ UTRs) and intronic regions. It was suggested that these nucleotide polymorphisms modify GlyRs expression and phenotypic behavior in humans contributing to an anxiety phenotype as a mild form of hyperekplexia. Hyperekplexia is a human neuromotor disorder with massive startle phenotypes due to mutations in genes encoding GlyRs subunits. GLRA1 mutations have been more commonly observed than GLRB mutations. If an anxiety phenotype contributes to the hyperekplexia disease pattern has not been investigated yet. Here, we compared two mouse models harboring either a mutation in the murine Glra1 or Glrb gene with regard to anxiety and startle phenotypes. Homozygous spasmodic animals carrying a Glra1 point mutation (alanine 52 to serine) displayed abnormally enhanced startle responses. Moreover, spasmodic mice exhibited significant changes in fear-related behaviors (freezing, rearing and time spent on back) analyzed during the startle paradigm, even in a neutral context. Spastic mice exhibit reduced expression levels of the full-length GlyRs β subunit due to aberrant splicing of the Glrb gene. Heterozygous animals appear normal without an obvious behavioral phenotype and thus might reflect the human situation analyzed in the GWAS study on agoraphobia and startle. In contrast to spasmodic mice, heterozygous spastic animals revealed no startle phenotype in a neutral as well as a conditioning context. Other mechanisms such as a modulatory function of the GlyRs β subunit within glycinergic circuits in neuronal networks important for fear and fear-related behavior may exist. Possibly, in human additional changes in fear and fear-related circuits either due to gene-gene interactions e.g., with GLRA1 genes or epigenetic factors are necessary to create the agoraphobia and in particular the startle phenotype. KW - glycine receptor KW - spastic KW - fear KW - anxiety KW - startle reaction Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-210041 SN - 1662-5099 VL - 13 IS - 152 ER - TY - JOUR A1 - Schaefer, Natascha A1 - Roemer, Vera A1 - Janzen, Dieter A1 - Villmann, Carmen T1 - Impaired Glycine Receptor Trafficking in Neurological Diseases JF - Frontiers in Molecular Neuroscience N2 - Ionotropic glycine receptors (GlyRs) enable fast synaptic neurotransmission in the adult spinal cord and brainstem. The inhibitory GlyR is a transmembrane glycinegated chloride channel. The immature GlyR protein undergoes various processing steps, e.g., folding, assembly, and maturation while traveling from the endoplasmic reticulum to and through the Golgi apparatus, where post-translational modifications, e.g., glycosylation occur. The mature receptors are forward transported via microtubules to the cellular surface and inserted into neuronal membranes followed by synaptic clustering. The normal life cycle of a receptor protein includes further processes like internalization, recycling, and degradation. Defects in GlyR life cycle, e.g., impaired protein maturation and degradation have been demonstrated to underlie pathological mechanisms of various neurological diseases. The neurological disorder startle disease is caused by glycinergic dysfunction mainly due to missense mutations in genes encoding GlyR subunits (GLRA1 and GLRB). In vitro studies have shown that most recessive forms of startle disease are associated with impaired receptor biogenesis. Another neurological disease with a phenotype similar to startle disease is a special form of stiff-person syndrome (SPS), which is most probably due to the development of GlyR autoantibodies. Binding of GlyR autoantibodies leads to enhanced receptor internalization. Here we focus on the normal life cycle of GlyRs concentrating on assembly and maturation, receptor trafficking, post-synaptic integration and clustering, and GlyR internalization/recycling/degradation. Furthermore, this review highlights findings on impairment of these processes under disease conditions such as disturbed neuronal ER-Golgi trafficking as the major pathomechanism for recessive forms of human startle disease. In SPS, enhanced receptor internalization upon autoantibody binding to the GlyR has been shown to underlie the human pathology. In addition, we discuss how the existing mouse models of startle disease increased our current knowledge of GlyR trafficking routes and function. This review further illuminates receptor trafficking of GlyR variants originally identified in startle disease patients and explains changes in the life cycle of GlyRs in patients with SPS with respect to structural and functional consequences at the receptor level. KW - glycine receptor KW - startle disease KW - autoimmune antibodies KW - protein maturation KW - trafficking pathways Y1 - 2018 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-227531 VL - 11 IS - 291 ER - TY - INPR A1 - Schaefer, Natascha A1 - Janzen, Dieter A1 - Bakirci, Ezgi A1 - Hrynevich, Andrei A1 - Dalton, Paul D. A1 - Villmann, Carmen T1 - 3D Electrophysiological Measurements on Cells Embedded within Fiber-Reinforced Matrigel T2 - Advanced Healthcare Materials N2 - 2D electrophysiology is often used to determine the electrical properties of neurons, while in the brain, neurons form extensive 3D networks. Thus, performing electrophysiology in a 3D environment provides a closer situation to the physiological condition and serves as a useful tool for various applications in the field of neuroscience. In this study, we established 3D electrophysiology within a fiber-reinforced matrix to enable fast readouts from transfected cells, which are often used as model systems for 2D electrophysiology. Using melt electrowriting (MEW) of scaffolds to reinforce Matrigel, we performed 3D electrophysiology on a glycine receptor-transfected Ltk-11 mouse fibroblast cell line. The glycine receptor is an inhibitory ion channel associated when mutated with impaired neuromotor behaviour. The average thickness of the MEW scaffold was 141.4 ± 5.7µm, using 9.7 ± 0.2µm diameter fibers, and square pore spacings of 100 µm, 200 µm and 400 µm. We demonstrate, for the first time, the electrophysiological characterization of glycine receptor-transfected cells with respect to agonist efficacy and potency in a 3D matrix. With the MEW scaffold reinforcement not interfering with the electrophysiology measurement, this approach can now be further adapted and developed for different kinds of neuronal cultures to study and understand pathological mechanisms under disease conditions. KW - 3D cultures Y1 - 2019 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-244194 ER - TY - JOUR A1 - Salehi, Saeede A1 - Zare, Abdolhossein A1 - Prezza, Gianluca A1 - Bader, Jakob A1 - Schneider, Cornelius A1 - Fischer, Utz A1 - Meissner, Felix A1 - Mann, Matthias A1 - Briese, Michael A1 - Sendtner, Michael T1 - Cytosolic Ptbp2 modulates axon growth in motoneurons through axonal localization and translation of Hnrnpr JF - Nature Communications N2 - The neuronal RNA-binding protein Ptbp2 regulates neuronal differentiation by modulating alternative splicing programs in the nucleus. Such programs contribute to axonogenesis by adjusting the levels of protein isoforms involved in axon growth and branching. While its functions in alternative splicing have been described in detail, cytosolic roles of Ptbp2 for axon growth have remained elusive. Here, we show that Ptbp2 is located in the cytosol including axons and growth cones of motoneurons, and that depletion of cytosolic Ptbp2 affects axon growth. We identify Ptbp2 as a major interactor of the 3’ UTR of Hnrnpr mRNA encoding the RNA-binding protein hnRNP R. Axonal localization of Hnrnpr mRNA and local synthesis of hnRNP R protein are strongly reduced when Ptbp2 is depleted, leading to defective axon growth. Ptbp2 regulates hnRNP R translation by mediating the association of Hnrnpr with ribosomes in a manner dependent on the translation factor eIF5A2. Our data thus suggest a mechanism whereby cytosolic Ptbp2 modulates axon growth by fine-tuning the mRNA transport and local synthesis of an RNA-binding protein. KW - molecular neuroscience KW - RNA-binding proteins KW - RNA transport Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-357639 VL - 14 ER - TY - THES A1 - Saal, Lena T1 - Whole transcriptome profiling of compartmentalized motoneurons T1 - Globale Transkriptomanalyse von kompartimentierten Motoneuronen N2 - Spinal muscular atrophy and amyotrophic lateral sclerosis are the two most common devastating motoneuron diseases. The mechanisms leading to motoneuron degeneration are not resolved so far, although different hypotheses have been built on existing data. One possible mechanism is disturbed axonal transport of RNAs in the affected motoneurons. The underlying question of this study was therefore to characterize changes in transcript levels of distinct RNAs in cell culture models of spinal muscular atrophy and amyotrophic lateral sclerosis, especially in the axonal compartment of primary motoneurons. To investigate this in detail we first established compartmentalized cultures of Primary mouse motoneurons. Subsequently, total RNA of both compartments was extracted separately and either linearly amplified and subjected to microarray profiling or whole transcriptome amplification followed by RNA-Sequencing was performed. To make the whole transcriptome amplification method suitable for compartmentalized cultures, we adapted a double-random priming strategy. First, we applied this method for initial optimization onto serial dilutions of spinal cord RNA and later on to the compartmentalized motoneurons. Analysis of the data obtained from wildtype cultures already revealed interesting results. First, the RNA composition of axons turned out to be highly similar to the somatodendritic compartment. Second, axons seem to be particularly enriched for transcripts related to protein synthesis and energy production. In a next step we repeated the experiments by using knockdown cultures. The proteins depleted hereby are Smn, Tdp-43 and hnRNP R. Another experiment was performed by knocking down the non-coding RNA 7SK, the main interacting RNA of hnRNP R. Depletion of Smn led to a vast number of deregulated transcripts in the axonal and somatodendritic compartment. Transcripts downregulated in the axons upon Smn depletion were especially enriched for GOterms related to RNA processing and encode proteins located in neuron projections including axons and growth cones. Strinkingly, among the upregulated transcripts in the somatodendritic compartment we mainly found MHC class I transcripts suggesting a potential neuroprotective role. In contrast, although knockdown of Tdp-43 also revealed a large number of downregulated transcripts in the axonal compartment, these transcripts were mainly associated with functions in transcriptional regulation and RNA splicing. For the hnRNP R knockdown our results were again different. Here, we observed downregulated transcripts in the axonal compartment mainly associated with regulation of synaptic transmission and nerve impulses. Interestingly, a comparison between deregulated transcripts in the axonal compartment of both hnRNP R and 7SK knockdown presented a significant overlap of several transcripts suggesting some common mechanism for both knockdowns. Thus, our data indicate that a loss of disease-associated proteins involved in axonal RNA transport causes distinct transcriptome alterations in motor axons. N2 - Spinale Muskelatrophie und Amyotrophe Lateralsklerose zählen zu den beiden häufigsten und schwersten Motoneuronerkrankungen. Der zugrunde liegende Mechanismus beider Krankheiten ist bis heute nicht geklärt, dennoch werden verschiedene Theorien diskutiert. Ein möglicher Grund ist ein gestörter axonaler Transport von RNAs in den betroffenen Motoneuronen. Daraus folgernd ergab sich die zugrunde liegende Frage dieser Arbeit, ob Veränderungen in den Transkriptleveln bestimmter RNAs unter krankheitsähnlichen Bedingungen vor allem im axonalen Kompartiment von primären Maus-Motoneuronen beobachtet werden können. Um die Fragestellung genauer zu untersuchen, etablierten wir zuerst kompartimentierte Kulturen von primären Motoneuronen. Darauffolgend haben wir die totale RNA aus beiden Kompartimenten separat extrahiert und entweder diese linear amplifiziert und zur Microarrayanalyse gegeben oder wir führten eine Amplifikation des kompletten Transkriptoms mit anschließender RNA-Sequenzierung durch. Um die Amplifikation des kompletten Transkriptoms auch für die kompartimentierten Kulturen geeignet zu machen, verwendeten wir eine doublerandom priming Strategie und haben diese entsprechend angepasst. Zuerst wendeten wir die Methode an Serienverdünnungen von RNA aus dem Rückenmark an, um die Methode zu optimisieren. Später benutzten wir die Methode ebenfalls für kompartimentierte Motoneurone. Schon die Analyse der Wildtyp-Daten lieferte interessante Ergebnisse. Erstens, die Zusammensetzung der RNA in Axonen war höchst ähnlich zu der im somatodendritischen Kompartiment. Zweitens, in Axonen scheinen speziell Transkripte angereichert zu sein, welche mit Proteinsynthese und Energieproduktion in Verbindung stehen. In einem nächsten Schritt wurden dann die Experimente unter Verwendung von Knockdown-Kulturen wiederholt. Die Proteine, die dabei vermindert wurden waren Smn, Tdp-43 und hnRNP R. Ein weiteres Experiment wurde durchgeführt indem die nicht-codierende RNA 7SK verringert wurde. Die Depletion von Smn führte zu einer hohen Anzahl an deregulierten Transkripten sowohl im axonalen, als auch im somatodendritischen Kompartiment. Transkripte, die im axonalen Kompartiment nach Smn Depletion verringert waren, waren überwiegend für GOTerms angereichert, welche mit RNA Prozessierung in Verbindung stehen oder welche Proteine codieren, die in neuronalen Fortsätzen, einschließlich Axon und Wachstumskegel lokalisiert sind. Bemerkenswert ist, dass wir unter den hochregulierten Transkripten im somatodendritischen Kompartiment überwiegend MHC Klasse I Transkripte gefunden haben. Dies könnte eine mögliche neuroprotektive Rolle dieser Transkripte annehmen lassen. Im Gegensatz zu den Ergebnissen beim Smn Knockdown fanden wir beim Tdp-43 Knockdown ebenfalls eine große Anzahl an herunterregulierten Transkripten im axonalen Kompartiment, diese sind allerdings überwiegend mit Funktionen in der Transkriptionsregulierung und beim RNA Splicing assoziiert. Die Ergebnisse des hnRNP R Knockdowns waren ebenfalls unterschiedlich. Bei diesem fanden wir die herunteregulierten Transkripte im axonalen Kompartiment überwiegend mit einer Regulierung der synaptischen Übertragung sowie mit Nervenimpulsen assoziiert. Interessanterweise zeigte ein Vergleich der deregulierten Transkripte sowohl im axonalen Kompartiment vom hnRNP R Knockdown, als auch vom 7SK Knockdown eine signifikante Übereinstimmung mehrerer Transkripte. Dies lässt einen teilweise gemeinsamen Mechanismus für beide Genprodukte vermuten. Somit deuten unsere Daten darauf hin, dass ein Verlust von krankheitsassoziierten Proteinen, die eine Rolle beim axonalen RNA-Transport spielen, zu verschiedenen Transkriptomveränderungen in Axonen von Motoneuronen führt. KW - Axon KW - Motoneuron KW - Spinale Muskelatrophie KW - amyotrophic lateral sclerosis Y1 - 2017 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-140006 ER - TY - JOUR A1 - Saadat, S. A1 - Sendtner, Michael A1 - Rohrer, H. T1 - Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture N2 - Ciliary neurotrophic factor (CNTF) influences the levels of choline acetyltransferase (ChAT) and tyrosine hydroxylase (TH) in cultures of dissociated sYmpathetic neurons from newborn rats. In the presence of CNTF both the total and specific activity of ChAT was increased 7 d after culture by 15- and 18-fold, respectively, as compared to cultures kept in the absence of CNTF. Between 3 and 21 d in culture in the presence of CNTF . the total ChAT activity increased by a factor of >100. Immunotitration demonstrated that the elevated ChAT levels were due to an increased number of enzyme molecules. In contrast to the increase in ChAT levels, the total and specific activity levels' of TH were decreased by 42 and 36 %, respectively, after 7 d in culture. Half-maximal effects for both ChAT increase and TH decrease were obtained at CNTF concentrations of rvO.6 ng and maximal levels were reached at I ng of CNTF per milliliter of medium. The effect of CNTF on TH and ChAT levels were seen in serum-containing medium as well as in serum-free medium. CNTF was shown to have only a small effect on the long-term s.urviVal of rat sympathetic neurons. We therefore concluded that the effects of CNTF on ChAT and TH are not due to selective survival of cells that acquire cholinergic traits in vitro, but are rather due to the induction of cholinergic differentiation of noradrenergic sympathetic neurons. Y1 - 1989 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-32677 ER - TY - JOUR A1 - Rodriguez-Rozada, Silvia A1 - Frantz, Stefan A1 - Tovote, Philip T1 - Cardiac optogenetics: regulating brain states via the heart JF - Signal Transduction and Targeted Therapy N2 - No abstract available. KW - cardiology KW - neurology KW - neuroscience KW - systems biology Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-357625 VL - 8 ER - TY - JOUR A1 - Reddy, C. E. A1 - Albanito, L. A1 - De Marco, P. A1 - Aiello, D. A1 - Maggiolini, M. A1 - Napoli, A. A1 - Musti, A. M. T1 - Multisite phosphorylation of c-Jun at threonine 91/93/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons JF - Cell Death & Disease N2 - Cerebellar granule cell (CGC) apoptosis by trophic/potassium (TK) deprivation is a model of election to study the interplay of pro-apoptotic and pro-survival signaling pathways in neuronal cell death. In this model, the c-Jun N-terminal kinase (JNK) induces pro-apoptotic genes through the c-Jun/activator protein 1 (AP-1) transcription factor. On the other side, a survival pathway initiated by lithium leads to repression of pro-apoptotic c-Jun/AP-1 target genes without interfering with JNK activity. Yet, the mechanism by which lithium inhibits c-Jun activity remains to be elucidated. Here, we used this model system to study the regulation and function of site-specific c-Jun phosphorylation at the S63 and T91/T93 JNK sites in neuronal cell death. We found that TK-deprivation led to c-Jun multiphosphorylation at all three JNK sites. However, immunofluorescence analysis of c-Jun phosphorylation at single cell level revealed that the S63 site was phosphorylated in all c-Jun-expressing cells, whereas the response of T91/T93 phosphorylation was more sensitive, mirroring the switch-like apoptotic response of CGCs. Conversely, lithium prevented T91T93 phosphorylation and cell death without affecting the S63 site, suggesting that T91T93 phosphorylation triggers c-Jun pro-apoptotic activity. Accordingly, a c-Jun mutant lacking the T95 priming site for T91/93 phosphorylation protected CGCs from apoptosis, whereas it was able to induce neurite outgrowth in PC12 cells. Vice versa, a c-Jun mutant bearing aspartate substitution of T95 overwhelmed lithium-mediate protection of CGCs from TK-deprivation, validating that inhibition of T91/T93/T95 phosphorylation underlies the effect of lithium on cell death. Mass spectrometry analysis confirmed multiphosphorylation of c-Jun at T91/T93/T95 in cells. Moreover, JNK phosphorylated recombinant c-Jun at T91/T93 in a T95-dependent manner. On the basis of our results, we propose that T91/T93/T95 multiphosphorylation of c-Jun functions as a sensitivity amplifier of the JNK cascade, setting the threshold for c-Jun pro-apoptotic activity in neuronal cells. KW - c-Jun KW - JNK KW - cell death KW - neurons KW - trophic/potassium deprivation KW - lithium Y1 - 2013 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-128793 VL - 4 IS - e852 ER - TY - JOUR A1 - Rauschenberger, Vera A1 - von Wardenburg, Niels A1 - Schaefer, Natascha A1 - Ogino, Kazutoyo A1 - Hirata, Hiromi A1 - Lillesaar, Christina A1 - Kluck, Christoph J. A1 - Meinck, Hans‐Michael A1 - Borrmann, Marc A1 - Weishaupt, Andreas A1 - Doppler, Kathrin A1 - Wickel, Jonathan A1 - Geis, Christian A1 - Sommer, Claudia A1 - Villmann, Carmen T1 - Glycine Receptor Autoantibodies Impair Receptor Function and Induce Motor Dysfunction JF - Annals of Neurology N2 - Objective Impairment of glycinergic neurotransmission leads to complex movement and behavioral disorders. Patients harboring glycine receptor autoantibodies suffer from stiff‐person syndrome or its severe variant progressive encephalomyelitis with rigidity and myoclonus. Enhanced receptor internalization was proposed as the common molecular mechanism upon autoantibody binding. Although functional impairment of glycine receptors following autoantibody binding has recently been investigated, it is still incompletely understood. Methods A cell‐based assay was used for positive sample evaluation. Glycine receptor function was assessed by electrophysiological recordings and radioligand binding assays. The in vivo passive transfer of patient autoantibodies was done using the zebrafish animal model. Results Glycine receptor function as assessed by glycine dose–response curves showed significantly decreased glycine potency in the presence of patient sera. Upon binding of autoantibodies from 2 patients, a decreased fraction of desensitized receptors was observed, whereas closing of the ion channel remained fast. The glycine receptor N‐terminal residues \(^{29}\)A to \(^{62}\)G were mapped as a common epitope of glycine receptor autoantibodies. An in vivo transfer into the zebrafish animal model generated a phenotype with disturbed escape behavior accompanied by a reduced number of glycine receptor clusters in the spinal cord of affected animals. Interpretation Autoantibodies against the extracellular domain mediate alterations of glycine receptor physiology. Moreover, our in vivo data demonstrate that the autoantibodies are a direct cause of the disease, because the transfer of human glycine receptor autoantibodies to zebrafish larvae generated impaired escape behavior in the animal model compatible with abnormal startle response in stiff‐person syndrome or progressive encephalitis with rigidity and myoclonus patients. KW - glycine receptor autoantibodies KW - behavioral disorders KW - neurology Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-216005 VL - 88 IS - 3 SP - 544 EP - 561 ER - TY - JOUR A1 - Rauschenberger, Vera A1 - Piro, Inken A1 - Kasaragod, Vikram Babu A1 - Hörlin, Verena A1 - Eckes, Anna-Lena A1 - Kluck, Christoph J. A1 - Schindelin, Hermann A1 - Meinck, Hans-Michael A1 - Wickel, Jonathan A1 - Geis, Christian A1 - Tüzün, Erdem A1 - Doppler, Kathrin A1 - Sommer, Claudia A1 - Villmann, Carmen T1 - Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation JF - Frontiers in Molecular Neuroscience N2 - Glycine receptor (GlyR) autoantibodies are associated with stiff-person syndrome and the life-threatening progressive encephalomyelitis with rigidity and myoclonus in children and adults. Patient histories show variability in symptoms and responses to therapeutic treatments. A better understanding of the autoantibody pathology is required to develop improved therapeutic strategies. So far, the underlying molecular pathomechanisms include enhanced receptor internalization and direct receptor blocking altering GlyR function. A common epitope of autoantibodies against the GlyRα1 has been previously defined to residues 1A-33G at the N-terminus of the mature GlyR extracellular domain. However, if other autoantibody binding sites exist or additional GlyR residues are involved in autoantibody binding is yet unknown. The present study investigates the importance of receptor glycosylation for binding of anti-GlyR autoantibodies. The glycine receptor α1 harbors only one glycosylation site at the amino acid residue asparagine 38 localized in close vicinity to the identified common autoantibody epitope. First, non-glycosylated GlyRs were characterized using protein biochemical approaches as well as electrophysiological recordings and molecular modeling. Molecular modeling of non-glycosylated GlyRα1 did not show major structural alterations. Moreover, non-glycosylation of the GlyRα1N38Q did not prevent the receptor from surface expression. At the functional level, the non-glycosylated GlyR demonstrated reduced glycine potency, but patient GlyR autoantibodies still bound to the surface-expressed non-glycosylated receptor protein in living cells. Efficient adsorption of GlyR autoantibodies from patient samples was possible by binding to native glycosylated and non-glycosylated GlyRα1 expressed in living not fixed transfected HEK293 cells. Binding of patient-derived GlyR autoantibodies to the non-glycosylated GlyRα1 offered the possibility to use purified non-glycosylated GlyR extracellular domain constructs coated on ELISA plates and use them as a fast screening readout for the presence of GlyR autoantibodies in patient serum samples. Following successful adsorption of patient autoantibodies by GlyR ECDs, binding to primary motoneurons and transfected cells was absent. Our results indicate that the glycine receptor autoantibody binding is independent of the receptor’s glycosylation state. Purified non-glycosylated receptor domains harbouring the autoantibody epitope thus provide, an additional reliable experimental tool besides binding to native receptors in cell-based assays for detection of autoantibody presence in patient sera. KW - glycine receptor KW - autoantibodies KW - glycosylation KW - extracellular domain KW - adsorption Y1 - 2023 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-304206 VL - 16 ER -